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ABSTRACT 
 
“What do HIV patients and staff members think about when they hear the word „Side effect‟? 
Skin rashes, dizziness, nightmares, painful feet are some of the common side effects that 
patients on antiretroviral drugs (ARVs) experience once treatment is initiated on ARVs but it 
is said that these side effects are temporary and transient. Are patients and staff able to 
understand the concept of a side effect if they can or cannot understand the manifestation of 
this condition called HIV? Does a patient perceive a side effect as a good or bad thing and 
will the side effects change as our patients continue on the ARVs and become older? As the 
HIV programs progress over time should we not be educating our patients on the longer term 
side effects such as cardio toxicity, bone disorders and nephrotoxicity or are we of the 
opinion that we should not tell our patients about the long-term side effects in case it scares 
them and disrupts treatment? ” These are some of the questions that prompted this research 
study. The researcher explored the practices at two public healthcare facilities in order to 
understand the knowledge, perception and attitudes of the side effects of ARVs amongst staff 
and HIV patients. A total of sixty two (62) HIV patients and twenty five (25) staff members 
participated in this research study and the researcher used both the quantitative and 
qualitative research methods to execute the study. The objectives of the study were: 
 To assess the knowledge, perception and  attitude  of the  side effects of ARVs amongst 
staff and HIV patients  at KHC and GDH  
 To identify current practices at KHC and GDH that support  the understanding and 
knowledge of the side effects of ARVs amongst staff and HIV patients 
 To identify the gaps between the knowledge and existing practises amongst staff and HIV 
patients  at KHC and GDH 
 To provide recommendations  to  improve the perception, attitude and knowledge about 
the side effects of ARVs amongst staff and HIV patients  
It was found that the patients and staff are knowledgeable about the common side effects of 
ARVs but patients have the need to be informed about as many side effects as possible in 
order for them to understand their condition. It is further recommended that support groups, 
counselling services and health talks be provided at facilities to encourage the understanding 
of the side effects of ARVs amongst all patients and staff members.   
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OPSOMMING 
 
"Waaroor dink MIV-pasiënte en personeellede wanneer hulle die word “newe-effekte " hoor? 
Veluitslag, duiseligheid, nagmerries, pynlike voete is 'n paar van die algemene newe-effekte 
wat pasiënte op anti-retrovirale middels (ARMs) ervaar nadat hulle behandeling begin op 
ARMs en dit word gesê dat hierdie newe-effekte tydelik en verbygaande is. Is pasiënte en 
personeel in staat om die konsep van 'n newe-effekte verstaan as hulle dalk nie  die 
manifestasie van MIV kan verstaan nie? Dink 'n pasiënt dat   newe-effekte „n goeie of n 
slegte eienskap is en dink hulle die newe-effekte sal verander soos pasiënte op die ARMs 
verouer? Moet ons nie ons pasiënte en personeellede oplei oor die langtermyn newe-effekte 
soos kardio toksisiteit, been-afwykings en nefrotoksisiteit of is u van mening dat ons dit 
liewers moet vermy as om patiente af te skrik en hulle behandeling te ontwrig? Hierdie is 'n 
paar van die vrae wat deur die navorser gevra word in hierdie navorsingstudie.                                                                                                                                                                                              
Die navorser ondersoekdiepraktykeby twee openbaregesondheidsorgfasiliteite om ten 
eindediekennis,persepsies en houdingsvan dienewe-effekte vanARMsinpersoneel enMIV-
pasiëntete verstaan. 'n Totaalvan sestig(62) MIV-pasiënte envyf en twintig(25)personeellede 
het in hierdienavorsingstudiedeelgeneemendie navorser het beide die kwantitatiewe 
enkwalitatiewe navorsingsmetodesgebruikomdiestudieuit te voer.  
Diedoelwittevan die studiewas om: 
• diekennis,persepsie enhoudingvan dienewe-effekte vanARMste assesseeronderpersonneel 
en pasiëntebyKHCenGDH 
• huidigepraktykebyKHCenGDHwat ondersteuning bied virdiebegrip en kennisvan dienewe-
effekte vanARMsonder personeel enMIV-pasiëntete identifiseer 
• diegapingstussen diekennis enbestaande praktykeonder personeel enMIV-pasiëntete 
identifiseerbyKHCenGDH 
• aanbevelingste voorsienomdie persepsie, houding enkennisoor dienewe-effekte 
vanARMsonder personeel enMIV-pasiëntete verbeter 
Daar is bevind dat die pasiënte en personeel goed ingelig is oor die algemene newe-effekte 
van ARMS, maar pasiënte wil oor die meeste newe-effekte ingelig word om ten einde hul 
toestande te verstaan. Dit word verder aanbeveel dat ondersteuning groepe, beradingsdienste 
en gesondheid gesprekke voorsien moet word om die begrip van die newe-effekte van ARMS 
onder alle pasiënte en personeel aan te moedig. 
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GLOSSARY OF KEY TERMS 
  
 
CD4                                                  CD4 cell or T4 „helper‟ lymphocyte  
 
Incidence                                           The number of new HIV infections in a population  
                                                         over a specific time period. 
 
Opportunistic infections                     These are infections that are caused by HIV when the     
                                                         immune system is weak. Examples of opportunistic  
                                                         infections include TB, pneumocystic pneumonia,    
                                                         Cryptococcal meningitis and oesophageal candidiasis  
 
Peer education                                   This refers to the education of persons by persons  
                                                        of the same age, rank, social status, occupation,  
                                                        class or category (peers).    
 
Prevalence                                        The number of HIV infections as a proportion of a  
                                                        population at a specific time period. 
 
Viral load                                         This is a measurement of the HI-virus in the blood        
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CHAPTER 1            INTRODUCTION 
 
1.1 Introduction 
“We don‟t tell our patients the side effects of ARVs otherwise they will not take their 
medicines” (GDH,  2012).This was the ephemeral comment that initiated this research study 
and it is one of the few studies that explores this topic. It provides us with the baseline 
knowledge and insight into the knowledge, perception and attitudes of staff and HIV patients 
towards the side effects of ARVs.  
 
1.2 Background 
 
HIV and AIDS have undoubtedly been recognized as one of the greatest challenges of the 
21
st
 century. Africa, a global continent of  53 countries (www.infoplease.com) has not 
escaped the doom and devastation of the HIV and AIDS epidemic, with a reported 
occurrence of 1.837 million new HIV infections in adults and children in 2011 and a loss of 
1,223 million deaths between 2005 and 2011 (UNAIDS, 2011).At the southern tip of the 
continent of Africa lies South Africa, a country with a population of 50.59 million                     
persons (Stats. SA, 2011 midyear population estimate) and a country with a rich diversity and 
plethora in science, history, politics, geography,cultures, languages, economies and its 
people. South Africa  is known to have the highest burden of people living with HIV and 
AIDS  in the world and it has been reported that 5.6 million persons are living with HIV ,with 
5.1 million being adults above the age of 15 years  of which 2.9 million of  adults are women 
(UNAIDS,2011).The prevalence of HIV amongst the 15 – 49 year old age group in the 
general population in South Africa is 17.30% (UNAIDS,2011) . 
 
South Africa is divided into nine  provinces of which the Northern Cape is the largest 
province with a land surface area equating to 30.5% of the total area of South Africa 
(Southafrica.info, 2011) but with the smallest population in the country of 1, 906,731 million 
persons (StatsSA, midyear population estimates, 2011).The key economic sectors of the 
province are mining, agriculture, forestry and tourism but poverty and unemployment are  
some of the challenges that contribute to the proliferation of the HIV epidemic as many 
households live below the poverty line of R800 per month (DoHPSP,2011).The HIV 
prevalence in the general population (15-49 years of age) in the Northern Cape for 201l  is   
9.23% which is the second lowest in South Africa but the province continues to face 
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challenges such as the highest syphilis prevalence rate in the country of 3.8% in 2011 
(NDoH,2012) and the third highest TB burden equating to a reported TB incidence of 358 per 
10 000 persons  in 2010 ( DoH PSP,2011). The NDOH Antenatal survey 2012 reported an 
Antenatal HIV prevalence rate of 17% for the Northern Cape which is the lowest in the 
country but evidently it evokes questions as the highest HIV prevalence rate amongst 
pregnant women in the survey is the 30-34 year old population (NDoH ANC survey, 2012).  
 
It is therefore of utmost importance that the population of the Northern Cape remains healthy 
because of its small population size and the future economic growth of the province.      
The province is subdivided into five  districts of which Kimberley, the capital city of the 
Northern Cape is situated in the Frances Baard District. Frances Baard has the largest 
population of 375 167 persons and the second highest HIV prevalence of 18.4%  amongst 
pregnant women( NDoH Antenatal survey, 2012).The John Taole Gaetsewe District has the 
highest HIV prevalence of 27.5%  amongst pregnant women (PSP, 2012).Females have a  life 
expectancy of 57.4 years whereas males have a lower life expectancy of 54.1 years 
( StatsSA,midyear population estimates, 2011).The Northern Cape has a projected estimate 
HIV incidence of 0.7% (or 3177 new HIV infections per annum) which accounts for  0.9% of 
South Africa‟s new infections (PSP,2012). HIV is the seventh highest cause of death in the 
Northern Cape amongst all age groups with TB , influenza   and pneumonia reported as the 
main causes of death(StatsSA, 2008). 
 
The Comprehensive, Care, Management and Treatment (CCMT) program is located in the 
National and Provincial departments of Health to strategically address the Millenium 
development goals (MDGS) of the HIV epidemic. The provincial CCMT program aligns its 
vision and objectives to that of the NDOH to support the activities in curtailing the HIV 
epidemic and it focuses on key priority areas such as HIV prevention, treatment, care and 
support; research monitoring and surveillance; access to justice and the protection of human 
rights. The CCMT program for adults in the Frances Baard district was piloted at the  
Kimberley Hospital Complex (KHC) in 2004 and the Galeshewe Day Hospital (GDH) in 
2008 and over the past nine years the program has expanded to the provision of ART (anti-
retroviral therapy) at every health facility in the province.Over the years newer scientific 
discoveries and drug developments induced changes in the ART program and this 
necessitated the revision of policies which resulted in providing more access to health 
services and the provision of ART at an earlier stage to clients. With the rollout of ARVs 
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more staff were trained in the management of HIV and AIDS; nursing sisters were trained to 
perform HCT and to initiate new patients on NIMART. HCT, PMTCT and male circumcision 
was strategically prioritised in all facilities to reduce the provincial HIV prevalence and 
incidence. As at September 2012 there were 27588 persons (adults and children) on the 
provincial ART program (DoH, 2012). The Frances Baard district has a total number of 
12780 persons (adults and children) on the ART program (DOH, 2012). 
Antiretroviral therapy involves the provision of antiretroviral drugs (ARVs) to people living 
with HIV and AIDS to improve the quality of life and decrease patient mortality and 
morbidity. ARVs are provided to patients at public health facilities free of charge according 
to a specific process and criteria. The patient will undergo the necessary clinical consultation 
and readiness program before initiation on ARVs. All HIV positive patients who test positive 
with a CD4 count of <350 cell/mm
3
, pregnant mothers, TB/HIV co-infected patients, CPR 
positive infants and any other category of eligible patients are initiated on antiretroviral 
treatment as per the revised national policy of August 2011( NDOH,2011).Once the patient 
has completed the readiness assessment and the clinician is satisfied, the patient will be 
initiated on a standardised regimen and  be dispensed one  month‟s supply of ARVs with a 
follow-up date to return to the clinic within 28 days. It is required of professional healthcare 
providers such as the Pharmacist, post basic Pharmacist Assistant or Nurse to dispense the 
ARVs and counsel the patient explaining the treatment, dosaging instructions, possible drug 
interactions and the side effects. 
Patients are routinely initiated on treatment regimens known as regimen 1 or regimen 2.  
Regimen 1 involves the initiation of the adult patient on Tenofovir (TDF), Lamivudine (3TC) 
and Efavirenz (EFV) or on Stavudine (D4t), 3TC and EFV. A pregnant mother who is HIV 
positive would routinely be initiated on Nevirapine (NVP), 3TC and TDF. In pregnancy the 
treatment regimen is changed because of the toxicities of the ARVs (namely EFV) and the  
potential side effects of the drug on the foetus during gestation as well as during lactation. 
A patient is expected to continue using the prescribed ARVs for his/her lifetime unless he/she 
experiences any severe side effect or an adverse reaction to the ARV drugs. It is expected of 
the patient to adhere to the treatment dosaging schedule as it was provided by the health 
provider. An adherence level of 95 % is acceptable but an adherence level above 95% is 
considered “excellent” as it is indicative of “sound” adherence practices. The routine 
quantitative assessment of the viral load  and CD4 count of the patient often serves to verify 
whether a patient is taking his/her ARVs, as a high CD4 count and a low or undetectable viral 
load is the overall objective in managing the patients‟ condition. Before treatment with ARVs 
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the CD4 count will be low and the viral load will be high but once a patient commences 
treatment with ARVs, the CD4 count is expected to increase and the viral load will decrease 
to 100,000 copies/ml or until it is „undetectable‟.  A clinician would alter the treatment 
regimen in consultation with the patient to obtain an alternative positive clinical outcome if 
the above management objectives have not been met. Before patients are initiated on 
treatment the health care provider (staff member) at the clinic would counsel the patients and 
prepare them for the possible side effects of ARVs. This is done to prevent the patients 
defaulting or discontinuing the ARVs when they are on treatment. It is known that a patient 
could develop resistance to ARVs and this could lead to the transmission of the HI resistant 
virus. Counselling for patients on ART is provided by the clinician, nursing sister, adherence 
counsellor, social worker or psychologist, Pharmacist and the Post basic Pharmacist 
Assistant. The adherence counsellors perform a monthly pill count on the patients‟ ARVs and 
they will check for any possible reasons for nonadherence to treatment, misunderstanding or 
hindrances to compliance as patients may experience other social or personal issues such as 
the lack of food, lack of money for transport to the clinic, stigma, discrimination and it then 
requires the referral of the patient to the clinician, nurse, dietician or social worker for 
additional support. The interdisciplinary team at the facility has a responsibility to support 
treatment adherence and to mitigate any barriers that prevent patients from understanding 
their treatment regimen. 
The side effects of ARVs are varied and extensive as one simply needs to read a package 
insert of ARV products to understand the complexity and overlap of the side effects in two or 
more ARVs. The side effects of ARVs are well documented but it still requires constant 
monitoring and reporting as the safety data of these drugs are limited to pre-registration  
clinical trials and the use of small and not large population sample sizes (Republic of South 
Africa,2009). The safety of ARVs in large populations is a therefore a challenge in the 
optimal management of patients. 
 
1.3 Rationale for the research study 
 
Side effects can be regarded as early side effects, medium side effects and late side effects 
with four major categories of side effects of patients on ARVs such as mitochondrial toxicity, 
metabolic abnormalities, hematologic abnormalities and allergic reactions (Republic of South 
Africa,2009).The patient could experience possible acute and long term side effects caused 
by the drug itself or by an interaction of the ARVs with food, herbal medicines, or traditional 
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medicines. Patients may not be aware that these side effects could be mild or fatal (death) 
with physical, mental or psychological changes occurring in their bodies.  It is therefore 
important for the patient and staff to understand the side effects of ARVs to optimally 
manage and prolong the life of the patient. 
As patients live longer on antiretroviral therapy, more complications occur and it is important 
that the patient is correctly informed to prevent complications of the side effects and non- 
adherence to treatment. The patient is generally informed of the “common” or basic side 
effects of ARVs such as nausea, vomiting, skin rashes, headache, nightmares or painful feet 
or legs. As soon as patients‟ experience any side effect they should inform the doctor or nurse 
about this, as the health provider needs to complete the adverse reaction form for further 
processing to the specific district and depot pharmacist in the province. The district 
pharmacist collates the data and submits the report to the KHC pharmacist and thereafter it is 
forwarded to the Medicine Control Council (MCC) and National Adverse Events Monitoring 
Centre (NADEMC) for further responses by the respective manufacturers. The MCC 
responds to any potential safety hazard on an ARV, as well as any other medicine to ensure 
that quality and safe medicine and ARVs are produced and availed to clients. The current 
status of adverse events monitoring and the reporting of ARVs in the province is not optimal 
due to various challenges and constraints. 
It is equally important that patients are informed about the side effects of TB drugs and other 
common medicines such as hypertensive drugs, analgesics or diabetes medication to avoid 
the stoppage of any treatment or medication. 
Patients have access to modern electronic technologies such as smart cellular phones, iPods, 
kindles, social media networks, television and the internet that allows them to access more 
information on ARVs. It is expected that the patients on the ART programme know about the 
basic side effects of ARVs but do the patients “look for” and spontaneously report any 
changes or medium or late side effects? As they get older and as their bodies change both 
physically and metabolically, should patients and staff not be more observant?  
 
1.4 Research problem 
 
The provincial “roll out” of the CCMT program since September 2011 still presents 
challenges to patients and staff at healthcare facilities. At public healthcare facilities long 
queues of chronic patients, inadequate staffing and the expansion of more health programs 
with more administrative functions retards the provision of quality services. There is the 
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continual pressure to meet the provincial and facility CCMT targets, to spend financial ARV 
budgets and the need to meet various expectations from different stakeholders (including the 
patient). Long waiting times at consultation rooms result in impatient clients at the pharmacy 
who are often not prepared to listen, question staff about their ARVs or seek further advice to 
optimally manage their treatment plan and the side effects they experience. The Consumer 
Protection Act (CPA) 68 of 2008 requires that consumers of products (such as medicines) be 
comprehensively counselled with the benefits, side effects, warnings and cost clearly 
communicated to the patient (PSSA,2011) Healthcare workers have the professional 
responsibility of providing advice, information and counselling to the patient. The 
information can be provided in the format of instructions and labelling of medications, 
patients information leaflets, posters, simple communication in an acceptable language, 
health education talks, health campaigns and counselling services. 
 
 It is not known at which stages of the treatment plan information is provided about the side 
effects of ARVs to patients, how this information is provided to patients and how the patients 
understand this knowledge to apply it to them. It is also not known if the staff (who are 
required to provide this information to the patients) are knowledgeable about the side effects 
of ARVs and whether they are aware about the provincial and national pharmacovigilance 
reporting systems. There appears to be a lack of standardisation in the practices to create  
awareness and educate staff and HIV patients about the side effects of ARVs. Further  
research is thus required to investigate the practices at these facilities in order to provide 
answers to the various questions. 
 
1.5 Significance of the study 
This research study was significant for the following reasons: 
Firstly it provided an understanding between treatment literacy, patient education and 
knowledge amongst patients and staff. Secondly, the study informed us whether the current 
services address the need and knowledge about the side effects of ARVs amongst staff and 
HIV patients. Thirdly, the study provides information about the perception of the side effects 
of ARVs amongst staff and HIV patients so that it informs us how staff and patients perceive 
a side effect. It provides an understanding between  the perception of  side effects and  
knowledge in managing HIV using ARVs. The studyinforms us whether the patient or staff 
member sees the need to report an ‟experienced „side effect to the respective persons or 
authorities. The process of the reporting of a side effect from patients and staff is a voluntary 
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process but it enables the patient and healthcare worker to contribute more positively to the 
management of the patient‟s condition and also to the management of the pharmacovigilance 
program in the province. Fourthly, the correct management of the side effects could lead to 
less defaulting or discontinuation of treatment by patients, less ARV resistance and a more 
cost effective CCMT program. An understanding of the side effects of ARVs encourages 
adherence to treatment which results in less defaulting or “lost to follow ups” on the CCMT 
program and in return this prevents the spread of the HI- resistant virus. Less ARV resistance 
implies that more patients will be initiated on the standardised treatment regimens (such as 
regimen one) rather than the more expensive ARVs(such as regimen two and the newer 
ARVs) and this enables staff  to initiate more patients on ARVs as more financial resources 
would be available. Fifthly, the study provides information on the current practises at facility 
level in relation to the changing needs of the patients and staff. 
The outcomes of this study  provides  recommendations to improve the knowledge, 
perception and attitude about the side effects of ARVs in staff and HIV patients. 
 
1.6 Research Question 
The research question for this study was to determine to what extent the current practices at 
KHC and GDH address the knowledge, perceptions and attitude of the side effects of ARVs 
amongst staff and HIV patients 
 
1.7Aims and objectives 
1.7.1 Aim of the study 
The aim of the study was to establish to what extent the current provision of services at KHC 
and GDH in the Frances Baard district addresses the knowledge, perceptions and attitude of 
the side effects of ARVs amongst staff and HIV patients in order to improve the current 
practices. 
1.7.2 Objectives 
The objectives of the study were: 
 To assess the knowledge, perception and  attitude  of the  side effects of ARVs amongst 
staff and HIV patients at KHC and GDH  
 To identify current practices at KHC and GDH that support  the understanding and 
knowledge of the side effects of ARVs amongst staff and HIV patients 
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 To identify the gaps between the knowledge and existing practises amongst staff and HIV 
patients  at KHC and GDH 
 To provide recommendations to improve the perception, attitude and knowledge about the 
side effects of ARVs amongst staff and HIV patients. 
Having stated the significance of this research study with the aims and objectives, the 
research problem defines the scope of this study. It is hoped that a positive perception, 
attitude and knowledge about the side effects of ARVs in patients and staff would facilitate 
the management of HIV in patients.  
 
1.8   Research methodology 
This was an exploratory study and the researcher used both the qualitative and quantitative 
methods in the research design to follow the best approach. The study was conducted over six 
weeks at two public healthcare facilities in the Northern Cape namely, Kimberley Hospital 
Complex (KHC) and Galeshewe day hospital (GDH).A convenience sampling method was  
used as this was the most practical approach and a total of 25 staff members and 62 HIV 
patients participated in the study.                                 
 
1.9   Limitations of the study 
The sampling sites were limited to facilities where the CCMT programme was in existence 
for a period longer than three years and the sampling site needed to have a doctor, 
pharmacist, a nurse and an adherence counsellor at the wellness clinic of the facility. 
The target population had to be adults of 18 years or older. This excluded paediatric patients 
and adolescent patients younger than 18 years of age.                 
 
1.10   Outline of chapters 
The format of the research report is divided into the following chapters: 
Chapter 1 
This chapter provides a background to the research study, the rationale for the study, the                                                                                                                                      
research problem and the significance of the research study. It also describes the research 
question with the aim and the objectives of the research. 
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Chapter 2 
This chapter provides discussion around the existing knowledge and literature with relevance 
to the research problem. The reader is introduced to literature on key concepts such as 
knowledge, perception, attitudes, ARVs, side effects, legislation and adherence.  
Chapter 3 
In this chapter the methodology of the research study is discussed and it explains to the reader 
the research design, the research tools, the incurred costs and expenditure as well as the 
overall method of execution of the research study. 
Chapter 4 
This chapter presents the results and findings of the research study in the format of tables, 
graphs and brief comments. 
Chapter 5 
This chapter provides a detailed discussion of the results in relation to the preceding chapters 
(Chapters 1 to 4).  
Chapter 6 
This chapter of the report provides the reader with insight into the implications of the results 
and it provides recommendations to the study. 
Chapter 7 
This is the final chapter and the conclusion of the research report.  
 
1.11   Conclusion 
A review of the literature will be presented in the next chapter. 
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CHAPTER 2    LITERATURE REVIEW 
 
2.1 Operational definitions of the literature review 
2.1.1 Knowledge 
Knowledge is defined as facts, information, and skills acquired through experience or 
education; the theoretical or practical understanding of a subject (Oxford dictionary, 2012) 
2.1.2 Attitude 
Attitude is defined as the way that you think and feel about somebody/something; the way 
that you behave towards somebody/something that shows how you think and feel (Oxford 
advanced dictionary, 2012) 
2.1.3 Perception 
Perception is defined as a belief or opinion, often held by many people and based on how 
things seem (Cambridge dictionary, 2012) 
 
2.2 Antiretroviral drugs (ARVs)   
2.2.1 What are Antiretroviral drugs (ARVs)? 
ARVs are drugs that are used alone or in a combination form to manage HIV and AIDS but it 
does not cure you. ARVs retard the growth of the HI-virus enabling the immune system to 
function optimally and defend the body against any new opportunistic infections. The use of 
ARVs enables HIV patients to live longer and it provides them an improved quality of life. 
.Patients are provided with a combination of at least three ARVs in the form of a regimen as 
the different ARVs work at different stages of the lifecycle of the HI-virus. The ARVs work 
at different receptor sites in the body enabling the drugs to have both an effect and a side 
effect (or side effects) in the body. 
The Hi-virus mutates in the body if the immune system is weak or suppressed allowing the 
Hi-virus to replicate in the body and certain ARVs will no longer be effective. It is often 
referred to as “resistance” to the drugs (ARVs) and an alternative treatment regimen (such as 
regimen 2 or 3) must then be prescribed for the patient.  
2.2.2 Treatment regimens and ARVs 
The science and the development of ARVs gave rise to the use of various treatment regimens 
and the public health sector regimens have been standardised to optimally manage most of 
the patients. At the clinics and hospitals reference is made to regimen 1, regimen 2, a regimen 
for pregnant patients and also salvage therapy for patients who are not clinically stable on any 
of the previously mentioned regimens. 
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 The National Department of Health, RSA (2010)  standardised the following regimens for 
adults and adolescents as described in Table 2.1below. 
 
Table 2.1:National ART Regimens   
First Line 
All new patients needing 
treatment 
TDF + 3TC/FTC + 
EFV/NVP 
For TB co-infection EFV is 
preferred. For pregnant 
women or women of child 
bearing age, not on reliable 
contraception, NVP is 
preferred. 
Currently on d4T-based 
regimen with no side effects 
 
 
d4T+3TC +EFV/NVP Remain on d4T if well 
tolerated. Early switch with 
any toxicity. Substitute TDF 
if at high risk of toxicity(high 
BMI, older, female, TB 
treatment) 
Contraindication to TDF: 
renal disease 
AZT+3TC+EFV/NVP  
Second line 
Failing on a d4T or AZT 
based 1
st
 line regimen 
TDF+3TC/FTC+LPV/r Virological failure must be 
followed by intensive 
adherence management, as 
resuppression is often 
possible. If repeat VL 
remains >1000 in 3 months, 
despite adherence 
intervention, switch. 
Failing on a TDF-based 1
st
 
line regimen 
AZT+3TC+LPV/r Virological failure must be 
followed by intensive 
adherence management, as 
resuppression is often 
possible. If repeat VL 
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remains >1000 in 3 months, 
despite adherence 
intervention, switch. 
Salvage Therapy 
Failing any 2
nd
 line regimen Specialist referral Virological failure on 
protease inhibitors is almost 
always due to non-adherence. 
Intensively exploring and 
addressing issues relating to 
causes of non-adherence will 
most often lead to 
resuppression. If VL remains 
high, refer where possible, 
but maintain on failing 
regimen. 
Source:Clinical Guidelines for the Management of HIV & AIDS in Adults and 
Adolescents(NDoHRSA,  2010 ) 
 
2.2.3 Side Effects 
A side effect is defined as any unintended effect of a pharmacological product occurring at 
doses normally used in man, which is related to the pharmacological properties of the drug 
(Fomundam,2011).The early side effects of ARVs are gastrointestinal and flu-like symptoms, 
headache, dizziness, vivid dreams, rash and hepatitis. 
The study by Nzienguiet al (2006) was conducted in Gabon and it was concluded that 
patients want to be provided the complete drug information including the side effects and any 
difficulties that could be experienced. 
2.2.4 Adverse event management 
An adverse event is defined as a response to a drug which is noxious and unintended and 
which occurs at doses normally used in man (MSH RPM plus, n.d). 
Side effects are said to create barriers to adherence whereas adverse events result in patient 
morbidity and mortality (MSH, 2011). 
The NDoH (2010) provided the following guidelines to manage adverse events: 
1. Identify and assess the adverse event and its possible cause (e.g. medication, food, illness) 
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2. If the reaction is mild or moderate, the ART must be continued. The patient must be 
provided symptomatic treatment, counselled and monitored 
3. If the cause is a single ARV, a single substitution can be made except if the patient is in 
virological failure 
4. If the need is then to discontinue ARVs, all ARVs must be stopped together as 
discontinuing one ARV could lead to resistance 
5. If a patient experiences any life threatening side effects such as lactic acidosis, hepatitis, 
kidney toxicity, pancreatitis, severe rash or Abacavir hypersensitivity reaction, all ARVs 
must be interrupted immediately 
6. Adverse events must be recorded and reported regularly to the CCMT programme in the 
province. Serious adverse effects must be reported within 48-72 hours to the MCC or 
NADEMC.  
Table 2.2 lists the important ART adverse reactions as stipulated in the guidelines of the 
National Department of Health, RSA (2010).These guidelines are used at the public 
healthcare institutions in the Northern Cape.  
 
Table 2.2:   Important ART Adverse Reactions and Safety monitoring  
Antiretroviral Adverse Reactions Recommended safety 
Monitoring 
Didanosine(DDI) Peripheral neuropathy, GIT 
effects( bloating, flatulence, 
nausea, diarrhoea), 
hyperlactataemia , lactic 
acidosis, pancreatitis) 
Clinical 
Efavirenz(EFV) CNS disturbances 
(dysphoria, vivid dreams, 
distractedness, dizziness, 
depression) 
Skin rash, hepatitis 
Possible link to congenital 
abnormalities-avoid during 
1
st
 trimester 
Clinical 
Lamivudine(3TC) and Generally well tolerated Clinical 
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Emtricitabine(FTC) 
Lopinavir/Ritonavir GIT symptoms(mainly 
diarrhoea);lipid and glucose 
abnormalities, lipodystrophic 
changes 
Fasting cholesterol and 
triglycerides and glucose at 3 
months 
Nevirapine(NVP) Skin rash(from mild to life 
threatening) 
Hepatitis ( can be fatal) 
ALT(Alanine transaminases)          
at baseline and at week 2,3 
and 8,and 12 and any time 
hepatitis symptoms occur 
Stavudine(d4T) Peripheral neuropathy, 
lipodystrophy/atrophy 
,hepatic steatosis, 
hyperlactataemia, lactic 
acidosis, pancreatitis 
Clinical 
Tenofovir(TDF) Nephrotoxicity Check creatinine at 
baseline,monthlyx3,6 months 
and then annually 
Zidovudine(AZT) Bone marrow suppression 
(anaemia, neutropenia), GIT 
symptoms, lipoatrophy, 
myopathy, headaches, 
hyperlactataemia, and lactic 
acidosis 
FBC (Full blood count) at 
baseline, then at months 1,2,3 
and 6 
Source: Clinical guidelines for the management of HIV and AIDS in adults and adolescents, 
NDoH RSA, 2010. 
 
2.2.5 Costs  
The provision of ARVs is said to reduce the HIV infection rate by at least two thirds (Van 
Niekerk and Kopelman, 2008).Nadross (2008) says that in South Africa this is affordable as 
the cost of a large scale rollout of ARVs is balanced by the savings in the health sector (Van 
Niekerk and Kopelman, 2008).There is little information about the cost of treating the side 
effects of ARVs (acute or fatal) against the affordability of the large scale rollout of ARVs. 
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2.2.6 ARV product information 
There are 10 suppliers on the government tender HP13-2013 ARV (RSA, 2012) currently 
supplying ARVs to government pharmaceutical depots .Each ARV product is pre-packaged 
in a container with a package insert that provides details about the medication (use,, dosage, 
warnings, side effects and contra-indications) but often the package insert is not user friendly 
to the patient or health worker as it consists of technical, clinical terminology and language. 
At the facility level the package insert is often discarded in the waste bin as the ARV 
medicine bottle or packet of tablets/capsules is removed from the outer box or plastic package 
and the label is placed on the dispensed container. The outer box/package with the package 
insert is discarded in the refuse bin. Sometimes the ARVs would be repackaged and 
dispensed to the patient in a new container with the package insert also not provided to the 
patient. There is very little literature or pamphlets available from the supplier or manufacturer 
about the side effects of ARVs. “User friendly” patient information literature is needed to 
create more awareness and knowledge about the side effects of ARVs. Currently there is a 
lack of “patient friendly “literature from suppliers and manufacturers about the side effects of 
ARVs in any official language. 
A study by Schumaker et al (2008) concluded that patients had a concern about the toxicity of 
ARVs as they felt concerned if the side effects differed from their expectations. It was 
recommended that healthcare professionals need to be more sensitive about their attitudes to 
pharmaceuticals and the concerns of patients must be considered to improve ART 
programmes.  
 
2.3 Legislation    
 
 The Pharmacy Act No 43 of 1974 and the Medicines Control Act no 101 of 2004 regulate 
that all providers and dispensers of medicine have a professional obligation to inform clients  
(patients) about the medicine, the benefits, side effects and warnings of a medicine. “The 
pharmacist must counsel the patient on the common severe side effects or adverse effects or 
interactions and therapeutic contra-indications that may be encountered including the 
avoidance and the action required if they occur” ( Pharmacy Act,53 of 1974,PRE-257 ). 
 The Consumer Protection Act (CPA) 68 of 2008 was enacted on 01 April 2011 and it 
outlines the responsibilities of all providers towards consumers, including the consumers of 
ARVs. This Act protects the interest of consumers and the rights of patients such as the right 
to good quality, fair value and safe medicines. The provision of safe, good quality ARVs is of 
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paramount importance for the CCMT programme. This implies that consumers or patients 
must be comprehensively counselled so that the patients understand the medicine, the side 
effects, the benefits, the costs and the warnings. Package inserts and patient information 
leaflets and other forms of written communication must be provided to the patient.  
The understanding, knowledge and the implications of the Consumer Protection Act by staff 
and patients at healthcare facilities is unknown.     
2.3.1 Patient rights 
Patients have the right to receive clear and adequate advice with regards to the safe and 
effective use of medicines (including ARVs).  
2.3.2 Responsibilities of healthcare workers 
The Consumer Protection Act (CPA) 68 of 2008 holds health professionals accountable so 
that we provide adequate counselling to the patients. 
2.3.3 Dispensing and counselling 
An Australian study by Puspitasari.et al (2010) showed that pharmacists will provide verbal 
counselling for new prescriptions but infrequently provide written information or information 
for regular medicines. They attribute the lack of consumers‟ interest to low counselling rates 
and they recommend that strategies regarding pharmacist counselling practices must be 
developed to involve consumers in the process.  
The study by Basaket al (2009) recommends that the role of the pharmacist and the 
educational system must be adapted to meet the changing needs of patients. Part of this 
research study looks at the needs and expectations of patients and staff.  
The study by Du Pasquieret al (2008) concludes that the consumers‟ needs for information as 
well as their expectations of the pharmacy profession are important for adherence purposes. 
The Pharmacist should be able to tailor consumer information to the consumers  
needs and this study supports previous studies on adherence.  
In our study and our situation will the healthcare providers be able to tailor and meet the 
needs of patients to meet their expectations? 
Puspitasari et al (2009) supports the study that pharmacist counsel consumers less on the side 
effects, drug interactions, precautions, contraindications and storage but more on the 
directions for use, dose, medicine name and instructions of medicines. 
2.3.4 Standard Operating Procedures (SOPS) 
SOPS are designed to provide the guidance to the user on how to perform the required steps 
and action of the required function. The Northern Cape Provincial Standard Operating 
Procedures for Pharmaceutical Services developed SOPs to ensure that professionals comply 
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with legislation. The SOP on dispensing describes “dispensing” in four phases, namely phase 
1 asthe evaluation and interpreting of a script, phase 2 as the preparation and labelling of 
medicines , Phase 3 as the final checks and phase4 as the provision of information to the 
patient. In phase 4 the dispenser provides information to the patient on the correct medicine 
use; possible side effects; storage; drug -food interactions and the correct storage of 
medicines. The SOPS of KHC and GDH indicate that counselling can be done by a 
Pharmacist or Pharmacist Assistant (under the supervision of a Pharmacist) and the patient 
must be counselled on the „common‟ side effects and the appropriate action if the patient 
experiences the side effects.   
 
2.4 Pharmacovigilance (PhV) 
The outcome of the long term adverse effects of ARVs and the toxicity profile of ARVs is 
unknown but the monitoring of ARVs is important especially in large populations (WHO, 
2007).  
Patients who experience side effects and stop taking their ARVs lead to further problems, 
treatment failure and drug resistance .Pharmacovigilance is important for the safety of 
patients and to strengthen the ART programme and procedures in the health system.   
2.4.1 Spontaneous reporting 
A spontaneous report is an unsolicited communication by health care professionals or 
consumers that describes one or more adverse drug reactions(ADRs) in a patient who was 
given one or more medicinal products and that does not derive from a study or any data 
collection scheme( WHO, 2007 ) 
Insufficient training on the prevention and management of adverse drug reactions to ARVs is 
being provided and this results in poor reporting of the adverse effects of ARVs (Fomundam, 
2011). 
 
2.5 Communication models 
Lewis et al (1997) conducted a study on the pharmacist counseling of chronic patients and it 
was recommended that pharmacists use a different communication model to the traditional 
sender-receiver –message model. The pharmacist must take the patients need and level of 
understanding into account and counselling must be adapted to each patient to maximise 
therapeutic outcomes. The IHS Indian service model uses open ended questions with the 
pharmacist actively involved with the patient. The health communication model is said to 
enhance patient compliance and this model supports the IHS model. The need for effective 
Stellenbosch University  http://scholar.sun.ac.za
 18 
 
counselling is predicted to increase with the increase in chronic patients and studies have 
shown that pharmacists need to understand modern communication models to ensure that 
patients are maintained on drug therapy.  
A new model by Helena (PSSA, 2012) called the green card training model was introduced 
and implemented at Ermelo Hospital pharmacy. The model describes how small green cards 
are fixed to the shelves in pharmacies under the relevant drugs. The cards contain information 
on the drug indications, common side effects, and dosages for adults and children and 
expected drug interactions. This helps staff to remember the information when counselling 
the patients. Alongside this presentations are also conducted by the Pharmacists and 
Pharmacist assistants as part of their training to increase their knowledge, confidence and 
communication skills (PSSA, 2012).However it has not been indicated if the model has been 
tested in HIV patients.  
A study by Langlois-Klassenet al (2008) concluded that communication between patients and 
physicians is valuable as physicians could address issues such as potential herb- drug 
interactions and they could provide appropriate medical care. The study also showed that if 
physicians are willing to discuss herbal medicines with patients, patients will follow the 
advice from physicians and they will make more informed decisions about their health but an 
improvement in the physician- patients‟ communication is recommended.  
In our study could this finding apply to the side effects of ARVs as well? 
 
2.6 Interventions   
Various studies have provided various interventions and strategies to encourage patients to be 
more knowledgeable about their ARVs. 
2.6.1 Instructional strategies   
Fomundam (2011) says that “the information should meet the patients' needs to achieve the 
best therapeutic outcome”(pg 4). 
2.6.2 Behavioural strategies 
Fomundam (2011) says that “patients must be encouraged to perform self monitoring of the 
side and adverse effects of medicines”(pg 4).  
2.6.3 Motivational and empowerment strategies 
Fomundam (2011) says that “patients must be encouraged to adopt new beliefs, attitudes, 
values and health care providers must target education to fill in the gaps in their knowledge 
base” (pg 4). 
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Pharmacists have an important role to play in positive patient outcomes. A study by March et 
al(2007) measured patient knowledge  on drug toxicities(on a scale of 0 to 4) , the CD4 
counts and viral loads and participants also had to gauge their own quality of life  using a 
survey method. The study showed that with patient education, pharmacists were able to 
improve the patient outcomes significantly in their CD4 counts, viral load and drug related 
toxicities. The study by Cocohobaet al (2012) supports the study in that pharmacist 
counselling improves adherence and CD4 counts. 
A study by Clark et al (2007) assessed the effect of a clinical pharmacist-directed patient 
education program on the therapy adherence of first time TB patients and multidrug-resistant 
(MDR)-TB patients. They compared the adherence of patients in a group of58 patients when 
educated by nurses or pharmacists. The study showed that the patients‟ adherence to TB 
treatment improved when a pharmacist provided patient education as it addressed the patients 
‟complete need of pharmaceutical care.    
A study by Gupta et al (2010) was conducted in India amongst pharmacy and pharmacy co- 
workers to determine the availability, provision and knowledge of ARVs, attitudes towards 
HIV –infected persons and the self perceived need for training amongst community based 
pharmacies in an urban area of India. The study showed that there was a tremendous need for 
training on HIV theories and interventions were needed to reduce the stigma of those that 
stock ARVs towards HIV –infected persons. The study by Sheridan  et al (1997) showed that 
time, the lack of training was more of a barrier than remuneration in counselling HIV patients 
and that support staff were less confident in providing advice on the prevention of HIV. 
Adherence and other roles of the pharmacist were not part of their study. 
Van Tam et al (2011) conducted a study in Vietnam and concluded that „stigma is a strong 
barrier to adherence and it also shapes the patients‟ attitude, in the ways that patients receive 
treatment as patients felt they wanted more support” . 
 
2.7 Adherence 
The adherence of patients to antiretroviral therapy is important as it enables the patient to 
remain on the treatment regimen longer and this delays resistance to antiretroviral treatment. 
A study by Uzochukwu  et al (2009) showed that 75% of patients in southeast Nigeria were 
not adhering fully to the treatment regimen with an average number of 3.57 days off drugs 
per month. One of the reasons provided for the non-adherence was the physical discomfort 
(side effects) of ARVs amongst other reasons. The study by Garcia et al (2006) concluded 
that in patients who do not understand ART, 80% will fail therapy and become non-adherent. 
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They recommended that policymakers in Nigeria address the factors causing non adherence 
especially when scaling up on ARV treatment. 
It is said that adherence to treatment cannot be identified on the physical appearance of a 
patient. Healthcare workers have to be trained to measure adherence to treatment using tools.  
A. study conducted by Steel et al (2007) provides healthcare workers with a tool that is able 
to measure adherence and support the activities of healthcare workers at facilities.  This study 
supports other studies on adherence by emphasising the importance of “almost perfect 
adherence” for success on all treatment outcomes and less viral resistance.  Steel  et al (2007) 
argues that the “scale up” of patients of ARVs requires more interventions as non-adherence 
will result in more cost implications. This counter argues the study of Nattros as non- 
adherence and the use of alternative treatment regimens are more expensive. Steel  et al 
(2007) further argues that the interpretations of adherence by healthcare workers will affect 
the clinical outcomes and management of the patient.  Staff could misinterpret levels of non-
adherence if a standardised tool is not used. 
Support measures that enhance adherence and knowledge about ARVs include personalised 
printed medication, information and patient literacy materials. A study by Wong et al (2006) 
in South Africa concluded that the use of a culturally sensitive educational videotape  
could improve the patients‟ knowledge about medication and further studies must be 
encouraged using media technology. This study did not include the cultural practices in 
relation to the understanding of the side effects of ARVs amongst patients and staff.  
Sanjobo  et al (2008) conducted a study in Zambia with the aim to explore the patients and 
healthcare professionals‟ perceived barriers and facilitators to the patients‟ adherence to 
ART. It was found that the lack of communication and information about ART, lack of 
followup and counselling were part of the barriers to adherence.  
The level of knowledge of ARVs and the side effects amongst patients and staff at our 
healthcare facilities in the Northern Cape is unknown. A study conducted in the Eastern Cape 
Province showed that there were challenges in the treatment and follow up of patients on 
ART. These challenges included the lack of training of healthcare providers, difficulty in 
communicating adverse drug reactions by patients, insufficient pharmacovigilance reporting 
as well as poverty in managing patients (Ruud et al ,2012).This study also showed that there 
was a need to improve pharmacovigilance practices especially with the “down referral” of 
patients to primary health care facilities. The study recommended that junior staff be 
continuously trained to improve the management of ARVS and the management of 
pharmacovigilance activities. 
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The study by Sharma et al (2007) showed that counselling in the last six month influences the 
adherence of the patient to ART.A client will experience a side effect but a client measures 
satisfaction by measuring the time spent with a doctor, the waiting time and the way the 
patient is treated. The experience of a side effect did not influence the perception of patient 
satisfaction at a facility. The study by Bartlet et al (2002) supports the fact that we need to 
educate and manage the side effects of patients in order to maintain adherence, educate and 
motivate patients. The study by Hoang et al (2011) supports the need for effective patient 
education programs because of the poor understanding of HIV and AIDS. 
 
2.8 Patient literacy 
A study performed by Hoang  et al (2012) focussed on the importance of patient education 
around HIV and antiretroviral (ARV) medications.  This study assessed knowledge and 
perceptions of HIV patients in on an ARV education program and it showed that patients had 
knowledge about HIV, but the results raised concerns over the patients‟ knowledge about 
their ARV medication and its side effects. Patients were concerned about the use of ARVs 
and their side effects. Zuniga (2006) reported that patients and physicians had different  
impressions of the type and incidence of side effects. The study by Hoang et al (2012) 
showed that the patient education program was not addressing the poorly understood issues 
and HIV and AIDS. Kaliyaberumal et al (2004) provided guidelines in a knowledge, attitudes 
and practice Study (KAP study) and they used the KAP study to conduct an educational 
diagnosis of the community. 
 A study by Nachega et al (2012) measured the adherence; drug resistance and patient-
provider communication in 2035 HIV infected adults using a self reported questionnaire on 
adherence. This study showed that 57% patients reported a recall of 100% adherence, 18% 
reported drug resistance as a “good thing” and 71% of health care providers could offer 
practical recommendations about adherence. This study concluded that there is a critical need 
to improve patient-provider communication, to improve adherence and benefit the overall 
patients‟ health. A study by Negi et al (2006) assessed the knowledge, attitude and perception 
about HIV/AIDS among pregnant women in rural areas of Dehradun (India) and it was 
concluded that there was a need to increase the awareness of HIV/AIDS amongst illiterate 
and low socio economic people using all methods of information, education and 
communication. 
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A study by Manias  et al (2007) studied the perspectives of consumers with osteoarthritis and 
healthcare professionals and found that consumers lacked understanding of the complexity of 
medicines and that dedicated time must facilitate an exchange of information.  
In this study will our participants lack an understanding of their ARVs? 
 
2.9 Attitude 
It is important that the attitude of the healthcare provider enhances positive behaviour and   
positive health in an HIV patient. 
A study by Matheson  et al (1999) was conducted in communities measuring the attitude of 
pharmacists towards consumers and it was concluded that “if the negative attitude of the 
pharmacist is addressed, this would encourage more pharmacists to provide services and 
thereby improve service delivery”. It is important to deliver programs and address the needs 
of HIV patients. The study showed that pharmacists need to change their attitude and stigma 
towards patients with HIV to improve services. 
A study by Corice et al (2006) showed that “a concern for the views of consumers and the 
expanding role of nurses” may improve the health outcomes of consumers. 
In this study it would be of interest to understand the role of the adherence counsellors and 
other health providers in improving the health outcomes of the patients.  
A study by Sheridan  et al (1997) showed the need for training and greater communication in 
community pharmacies to add value and support to HIV patients, as this resulted in more 
positive relationships and attitudes towards HIV patients.  
The study by Williams  et al (2008)   concluded that consumers are unaware of the need, 
effectiveness and safety of all their medicines in chronic diseases but health professionals 
tend to focus on the directions of medicines and they believed that the risk of medication 
related adverse effects was overrated. It was concluded that the barriers and perceptions of 
consumers hamper the communication and partnerships with health professionals and this 
influences the effective communication, adherence and safety of medicines.  
Peralta  et al (2007) conducted a study in adolescents and demonstrated that adherence is 
improved when a patient –provide relationship incorporates trust, good communication, 
adequate education about medications, an overall perception of caring and the socio-cultural 
aspects is considered in the management of the patient.  
The study by Agu et al (2012) evaluated the knowledge and attitudes of HIV infected patients 
in Nigeria in which 3650 patients participated from 36 hospitals and data from 63.8% of 
participants were analysed. Routine counselling and education was provided to the 
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participants. A total of 80.1% participants accepted to have been counselled on adverse drug 
reactions and 60.8% knew what to do when they suspected an adverse event. The study found 
that the knowledge of adverse reactions were associated with gender, educational and the 
employment status of the patients. It was generally found that the participants reported good 
knowledge and positive attitudes to the adverse effects of their medicines .The researcher 
argue that this was the converse of previous studies and that the patient counseling and 
education on drug therapy provided to these patients, may have contributed to these findings 
and it was recommended for future studies. 
 
2.10 Perception 
Coateset al (1983) conducted a study on the patient perception of the side effects of cancer 
chemotherapy drugs in different age groups, sex, marital status, domestic situations, 
diagnosis, treatment and response amongst 99patients. It was found that the nonphysical side 
effects contributed to 54% of the most severe symptoms so the patients‟ perception of the 
severity of the side effects is useful as a “cost benefit balance”. The major physical side 
effects were vomiting, hair loss and nausea. The researchers concluded that depending on the 
patients‟ perception of the side effects of oncolytics, the clinicians could decide whether or 
not to use chemotherapy. However inHIV and AIDS the perception of the severity of the side 
effects cannot be used as a “cost benefit balance” to assess whether patients must be provided 
ARVs or not as the cost of ARVs is much more affordable and less costly than oncolytics 
drugs.  
A study was conducted by Home et al (2008) to understand the perceptions of physician and 
patients on the use of an intravenous ARV drug called Fuzeon®. It was found that the 
perceptions amongst staff and patients were disconnected and it was recommended that the 
doctors and patients work together to meet the optimal situation. The study also suggested a 
nursing intervention to improve the perceptions of side effects amongst patients and doctors. 
A study on neurotiscm by Johnson and Neilands (2007) showed that the perceptions of health 
and side effects in HIV patients were linked to the individual differences in patients. 
 
2.11 Conclusion 
 
The above studies indicate that there are diverging goals, knowledge, perception and attitudes 
about HIV, ARVs and the side effects of medicine. There appears to be a need for more 
studies about the understanding and communication between health care providers and 
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patients about the side effects of ARVs. In determining whether the participants of this study 
have a similar or dissimilar understanding of the side effects of ARVs, we needed to ask 
questions and find practical solutions. 
In the following chapter, the research plan for the study will be discussed. 
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CHAPTER 3       RESEARCH METHODOLOGY   
 
3.1 Introduction 
Christensen L.B. (2011) describes a research design as the outline, plan or strategy used to 
investigate the research problem.  
 
3.2 Problem statement  
It is not known at which stages of the treatment plan information is provided about the side 
effects of ARVs to patients, how this information is provided to patients and how the patients 
understand this knowledge to apply it to them. It is also not known if the staff (who are 
required to provide this information to the patients) are knowledgeable about the side effects 
of ARVs and whether they are aware about the provincial and national pharmacovigilance 
reporting systems. There appears to be a lack of standardisation in the practices that create 
awareness and educate staff and HIV patients about the side effects of ARVs. Further 
research is thus required to investigate the practices at these facilities in order to provide 
answers to the various questions. 
 
3.3 The research question 
The research question for this study was  to determine to what extent  the current practices at 
KHC and GDH address the knowledge, perceptions and attitude of the side effects of ARVs 
amongst staff and HIV patients? 
 
3.4Aims and objectives 
3.4.1 Aim of the study 
The aim of the study was to establish to what extent the current provision of services at KHC 
and GDH in the Frances Baard District addresses the knowledge, perceptions and attitude of 
the side effects of ARVs amongst staff and HIV patients in order to improve the current 
practices. 
3.4.2 Objectives 
The objectives of the study were: 
 To assess the knowledge, perception and  attitude  of the  side effects of ARVs amongst 
staff and HIV patients at KHC and GDH  
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 To identify current practices at KHC and GDH that support  the understanding and 
knowledge of the side effects of ARVs amongst staff and HIV patients 
 To identify the gaps between the knowledge and existing practises amongst staff and HIV 
patients  at KHC and GDH 
 To provide recommendations to improve the perception, attitude and knowledge about the 
side effects of ARVs amongst staff and HIV patients. 
 
3.5 The research approach  
The research survey was conducted over six  weeks from 08 November to 20 December 2012 
at the wellness clinics of KHC and GDH in the Frances Baard district of the Northern Cape.  
 
3.5.1 Design of the research study 
A survey research method was used to investigate the research problem. Christensen (2011) 
describes survey research as a non- experimental research method which uses questionnaires 
or interviews as research tools in the study. The survey method is generally used to explore 
and measure the attitudes, perception and knowledge of participants in a research study. A 
sample of participants is selected and this enables the researcher to generalise the results to a 
larger population (Christensen, 2011). 
A mixed method research design (that is both the quantitative and qualitative methods) was 
used to investigate the research problem. One of the advantages of this method is that it can 
combine the strengths of the quantitative and qualitative research methods and it can also 
minimise the weaknesses of the individual methods (Christensen, 2011).One of the 
disadvantages is that it is more costly and  more difficult to conduct than the individual 
qualitative or quantitative studies (Christensen, 2011).      
 
3.5.2 The sampling sites  
The two public healthcare facilities that formed part of the study included the Kimberley 
Hospital Complex (wellness clinic) and the Galeshewe Day Hospital (wellness clinic). KHC 
is a tertiary hospital and GDH is a community health clinic and the wellness clinics are 
entities managed within these facilities.  
 
Galeshewe Day Hospital is currently the largest wellness for adults in the FrancesBaard 
district in the Northern Cape Province. It is also the largest referral site in that it “down 
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refers” stable HIV patients to the local primary healthcare clinics or hospitals in the province 
for further continuation of the HIV patient on treatment. Kimberley Hospital Complex 
currently operates as the only tertiary hospital in the province and it also functions as a 
wellness clinic for all the Department of Health employees and private clients in the 
Province. Similarly HIV patients who attend the Kimberley Hospital Complex can also be 
“down referred” to secondary institutions (such as the District hospitals) and Primary 
healthcare clinics in the province if the client wishes to be referred. 
 The method which was used to select these two facilities was based on set inclusion criteria 
and the use of the convenience sampling method, as both facilities are located in Kimberley 
and are within 10 kilometres of each other. It was required that the  wellness clinics  had to be 
in existence for more than three  years in order to be included in the study and it had to 
provide ART services to a general adult population of ages 18 years and above. The facility 
needed to have a pharmacy and the staffing structure needed to consist of at least one 
Pharmacist, a Pharmacist Assistant, a clinical doctor, a nurse and an Adherence counsellor in 
order to be part of this study. The pharmacies on site at the facilities are managed by 
Pharmacists with the support of either the basic Pharmacist Assistants (in GDH) or basic and 
Post-basic Pharmacist Assistants (in KHC).The staff at the wellness clinics needed to be 
involved in either the prescribing or dispensing or the counselling of HIV patients.  
Of the 13 public healthcare facilities in Kimberley only two facilities met the inclusion 
criteria to be part of this study, namely Kimberley Hospital Complex (KHC) and Galeshewe 
Day Hospital community health centre (GDH). 
 
3.5.3 The research team 
The research “team” was composed of the researcher , a language practitioner who edited the 
documents and a statistician who assisted with the analysis of the data. Certified translators 
were utilised to translate the questionnaire and consent form for patients into the four 
predominant languages of the Frances Baard District viz. English, Afrikaans, Xhosa and 
Setswana. The consent form and questionnaire for staff were only available in English and 
Afrikaans as most staff are conversant in these two languages. 
 
3.5.4 The target population 
The participants (staff and HIV patients) were randomly selected with the proposed sample 
size of participants of 60 patients and15 staff members, but a response rate of 130% was 
achieved resulting in a sample size of 62 patients and25 staff members. The target population 
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of this study included adults above 18 years of age only. Minors were excluded from this 
study due to the practicality and personal nature of the questions. The staff participated 
voluntarily in the study and their occupational classifications included Adherence 
counsellors, Pharmacists, Doctors and Nurses. 
 At Galeshewe Day Hospital 59 patients and 12 staff members participated in the study and at 
Kimberley Hospital Complex six  patients and 13 staff members participated in the study.  
 
3.5.5 The sampling method  
At KHC, the wellness clinic for HIV patients operates only on a Thursday. At GDH the   
wellness clinic for HIV patients operates from Mondays to Fridays from 07h30 till 16h00. 
A pilot study of the questionnaires and consent forms for staff and HIV patients was 
conducted in Kimberley at a public healthcare facility called City clinic. The actual time to 
complete all forms (by the staff and patients) in the pilot study was approximately 45 
minutes. Amendments were then made to the original questionnaires to improve the 
understanding of the questions and to avoid confusion or misinterpretations of the questions 
by the participants. 
 An average „consultation‟ time that a patient is seen by a doctor, nurse, adherence counsellor 
or the pharmacist is  approximately  35 minutes per individual consultation. Theoretically this 
meant that every third patient had a chance of being randomly selected or included in the  
study. Since patients had the choice of voluntary participation in the study, it resulted in the 
researcher using the convenience sampling method as the approach for practical reasons. The 
staff that participated in this study were randomly selected using the convenience sampling 
method, because the staffing numbers at both facilities are small. With the small staffing 
population  at KHC and GDH ,the goal  was to obtain a response from 24 out of 25 staff 
members to obtain a 95% confidence level (Christensen, 2011). 
 
3.6 Ethical considerations 
It was required to obtain institutional approval from KHC, GDH and the Research Ethics 
Committee (REC) of the University of Stellenbosch (U.S.) before this study was conducted. 
Approval to continue with the research was received from the REC Committee (U.S) on 05 
November 2012.  
The participants in this study included participants from all races, gender, education levels 
and occupations and the participants had to be above 18 years of age. Participation in this 
study was anonymous and voluntary and it was required for all participants to complete a 
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consent form before they participated in the study. Participants were not coerced into the 
study as participants were allowed to withdraw from the study if they chose to do so. One 
male patient at KHC chose not to participate in the study due to time constraints and work 
obligations, as the waiting time at the wellness clinic already delayed him for work.  
The respect for persons and their autonomy is one of the ethical guidelines of research and 
the decision for non- participation was respected. Privacy and confidentiality before, during 
and after the research study was emphasised as a priority to all participants to ensure trust and 
participation from all the participants. Confidentiality was specified in the consent forms and 
this was explained to the participants by the researcher. The questionnaires indicated that the 
names or identifiers of participants were not required at any place on the answered 
questionnaires and this re-emphasised the importance of anonymity and privacy.  
The participants were randomly selected from both facilities and the researcher or the 
participants were not paid to conduct or participate in this study. 
 As part of ethical research principles, it was necessary to inform the participants that any 
discomfort they experienced during the study would be referred to a doctor on site at the 
facility for counselling or treatment. The goal of this research study is for the benefit of the 
patients and society by improving the practises and knowledge at these facilities. This follows 
the principle of beneficence and nonmaleficence. (Christensen, 2011). 
The privacy and storage of the data was emphasised to the participants to ensure their trust 
and to meet the ethical research standards. All collected data forms have been stored in a 
lockable cabinet in the data collectors‟ office and all electronic data has been stored on a 
computer with a restricted password access. 
It was also required of the researcher to comply with the standards of non-plagiarism as is 
required by the University of Stellenbosch. 
 
3.7Research instruments 
The researcher designed the research instruments (questionnaires, consent forms and 
interview sheets) for the study.                         
 
Data was collected using the designed tools namely a questionnaire for patients and a 
questionnaire for staff. The self administered questionnaire was completed by the staff and 
the patients. Where patients were not able to complete the questionnaire by themselves, the 
data collector interviewed the patients as a semi structured interview with the participant 
responding according to the responses on the questionnaire. The participant was handed a 
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copy of the questionnaire to follow the questions and to choose from the listed responses. 
This was done to limit any bias from the researcher.   
3.7.1. Questionnaire for patients    
This tool was designed to measure the knowledge, perception and attitude of the side effects 
of ARVs amongst HIV patients. This questionnaire was available in English, Afrikaans, 
Setswana and Xhosa. It consisted of 40 questions subdivided into general demographic 
questions, questions on knowledge, perception and attitude. The entire questionnaire was 
composed of five  open ended and 35 closed ended questions. When selecting an answer to 
the close ended questions, the participant had to tick a response in an answer box from the 
range of answers provided. The ordinal scale of measurement was used as part of this 
research study to measure the responses from the patients.  
3.7.2 Questionnaire for staff  
This tool was designed to measure the knowledge, perception and attitude about the side 
effects of ARVs as well as the attitude of staff when providing this information to the patient. 
This questionnaire was only available in English and Afrikaans as most staff are conversant 
in the basic languages. The questionnaire consisted of 41 questions consisting of six  open 
ended and 35 closed ended questions. When selecting an answer to the close ended questions, 
the participant had to circlea response from the range of answers provided. The ordinal scale 
of measurement was used as part of this research study to measure the responses from the 
staff.  
The questions were subdivided into four categories such as general demographic questions, 
questions about knowledge, perception and the attitudes about the side effects of ARVs.  
Both the questionnaires for patients and staff were divided into the different constructs to 
provide information for this research study on the practices at the facilities.  
It was decided to provide a tick box (for patients) and a circled response on the questionnaires 
(for staff) to avoid confusion with the data collection, data capturing and data verification 
processes.  
 
3.7.3 Patient records  
As part of the requirements of the REC, it was required of the researcher to include the 
“access to the patient‟s folder” in the consent form. This was included in the consent form of 
the patient only in the very last paragraph. The intention was to access the folder of the 
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patient in the presence of both the researcher and patient as it would only be accessed in 
illiterate patients upon their consent. Access would only be required to provide information 
about the patients current ARVs, if the patient did not have his/her supply of ARVs with 
him/her.  
In this research study it was not required to access a patients‟ folder as patients either knew 
their ARVs and their treatment regimen or they carried empty pill packets/containers with 
them which served as proof to the data collector. 
3.7.4 Observations 
During the research study, the data collector observed certain practices at the wellness clinics 
whilst collecting the data at the facilities. Christensen (2011) refers to this as “open 
observation” as the participant might not be aware that the data collector is observing them as 
part of the study. 
 
3.8 Data collection and analysis 
The data was only collected by the data collector once a week using the research tools.  
All staff who voluntarily participated in the study completed the consent form and the self-
administered anonymous questionnaire. Both the forms for the staff participants were 
collected from the facility on the day that the research tools were provided or it was collected 
the following week (if the staff member was too occupied that day). The consent form and 
the questionnaire was handed back to me (the data collector) in separately sealed envelopes to 
maintain confidentiality and anonymity. The patients who volunteered had the choice of 
either completing the self administered anonymous questionnaire by themselves or they could 
participate in a semi structured interview with the data collector. At the end of each weekly 
“data collection day”, all the completed questionnaires and consent form were placed in four  
separately sealed boxes for consent forms and questionnaires labelled „staff‟ and „patients‟. It 
was the intention to conduct a formal interview with illiterate respondents but this was not 
required as the semi-structured interview met the objective. The questionnaires and the 
consent forms for patients were available in the four  dominant languages namely English, 
Afrikaans, Setswana and Xhosa but the most practical medium in the study was English. 
The data was analysed by Professor Kidd (Department of Statistics, University of 
Stellenbosch). The aim of the analysis was to report any trends and tendencies from the 
collected data and results of the study. Explanations regarding the statistical design are 
provided in this report in the format of text, tables and graphs. The results of the study should 
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validate the research question, aim and objectives of this research study and in conclusion, 
recommendations have been provided to support the findings of the research study.  
 3.8.1 Data handling and security of data. 
The raw data was captured in a Microsoft Excel spreadsheet and a template designed by the 
statistician. The Statistica 11® software programme was used to format the charts and 
graphs. Each patient and each staff questionnaire had its own unique questionnaire number as 
a reference. The information was stored on a USB flash disk and other network drives on the 
computer. The backup of all data and documents was done to minimise any risks, losses or 
damage to the equipment. Only the statistician and the data collector had access to the  
electronic data, but access to this electronic data was restricted by a user password on the 
computer of the data collector and statistician. All hardcopies of the documents and data are 
being stored in a locked cupboard in the office of the data collector. The data will be 
destroyed after two  years. 
 
3.9 Conclusion 
The results of the study will be discussed in the following chapter. 
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CHAPTER 4    RESULTS 
  
4.1 Introduction 
 
The results and analysis of the data will be discussed in two main sections, namely the results 
from the staff questionnaires and the results from the patient questionnaires. The results from 
both the questionnaires are presented under the following four subsections:   
Section A: General demographic questions              
Section B: Questions on knowledge            
Section C: Questions on perception  
Section D: Questions on attitude 
The statistical analysis was performed by Professor M.Kidd(Department of Statistics, 
University of Stellenbosch) using the Statistica 11 ® software  and the results are presented 
in the form of frequency tables, charts (2D – two dimensional histograms and column bar 
charts).The mean test was applied to format the results descriptively. 
 
4.2 A. RESULTS FROM THE STAFF QUESTIONAIRES 
The proposed sample population size was twenty staff members in total but twenty five 
persons participated in the study (N = 25).The response rate for participation of staff in the 
study is 130%. 
Table  4.1    :   Response rate of total participants in the study (N = 25) 
Total proposed participants  
to be part of the study 
Total number participants in 
study 
Response rate (%) 
20 persons 25 persons (25/20) x 100%  = 130% 
response rate 
 
Table  4.2      :  Staff participation per facility 
 Staff participating(N = 25) Percentage participation 
KHC staff 13 (13/25) x 100% = 52.00 % 
GDH staff 12 (12/25) x 100%= 48.00% 
Total staff  25 (13+12) / 25 x 100% = 100% 
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The results of the staff questions are now discussed with a simplified analysis of the result 
included under each question and graph. 
 
A. GENERAL QUESTIONS 
 
Question 1: Age of the participants 
.
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Figure 4.1:   Number of participants vs. age 
The graph shows that 59% of the participants were in the 20-29 year old age group, 16% was 
in the 30-39 year old age group, 16% was  in the 40-49 year old age group and 12% was in 
the 50-59 year old age group. There was an equal distribution of participants between 30 and 
49 years of age, with the highest category being the 20-29 year old participants. This 
indicates that the age of most staff at the wellness clinicsis between 20 and 29 years of age 
and this is notable as this young group of participants is expected to manage and deliver 
services to patients of various ages. 
 
Question 2:  Gender of participants 
Histogram of Q2 gender
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Fig 4.2:   Number of participants vs. gender 
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The results show that 72% of the participants were female and 28% of the participants were 
male and this indicates that more female than male staff participated in the study. This 
corresponds in practise as there are more female staff  than male staff at the wellness clinics. 
 
Question 3: Highest Education level 
Histogram of Q3 education
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Figure    4.3    :  Number of participants vs. the highest education level   
From the graph it is observed that 80% of the participants have a university education 
whereas 12% of the participants completed grade 12(std 10) and 8% completed college. This 
indicates that the participants have a high education and literacy level and it would be 
expected that the participants are able to communicate in practise with the patients and other 
staff members.  
 
B. QUESTIONS ON KNOWLEDGE  
 
Question 4:   Can HIV be cured? 
Histogram of Question 4
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Figure    4.4   :   Number of participants vs. the  question “Can HIV  
                                 be cured?”  
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The results show that 100% of all participants think that HIV cannot be cured This 
knowledge is important as the knowledge of the patients are influenced by the knowledge of 
staff. All staff were knowledgeable that „HIV cannot be cured which is an important practice 
to follow.  
 
Question 5: What treatment is provided at a clinic/hospital to a person with HIV? 
Bar/Column Plot of Count of yes
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Figure   4.5    :  Number of participants vs. the knowledge of treatment at clinics 
The question was addressed to all staff as all staff were  involved  in the prescribing, 
counselling and dispensing of ARVs. All staff knew that only ARVs and other medicines are 
supplied at the facility, which indicates that all staff are familiar with the operational 
procedures at the clinic. 
 
Question 6: Do you know the names of ARVs? 
Histogram of Question 6
Spreadsheet9 in staff questionnaire.stw 80v*25c
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Figure   4.6  : Number of participants vs.knowledge of the names of ARVs 
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The  graph indicates that all staff are  knowledgeable about the names of ARVs. Examples of 
the generic names or the „common‟ abbreviated  names or the trade names of ARVs were 
provided. All staff were knowledgeable with regards to the names of ARVs as well as the 
dosage and frequency of the ART regimens. This is important especially if staff are involved 
in the counselling of patients.  
 
Question 7: Do you know the dosaging and frequency of ARVs? 
Histogram of Question 7
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Figure 4.7: Number of participants vs. knowledge of dosaging and  the frequency of  
                      ARVs 
It is observed that all participants (100%) knew the dosaging and the frequency of ARVs. 
They could provide examples of the ARVs with its dose and frequency of the treatment 
regimen. This is essential as staff are required to know this as they are involved in the 
counselling and the management of HIV patients. 
 
Question 8:  What is a side effect? 
This was an open ended question and various responses were obtained. The question was 
included to validate the participant‟s knowledge and understanding of the side effect of 
ARVs. The participant could either explain this by means of a theoretical description of the 
term “side effect” or a practical example . 
The responses ranged from a pharmacological definition such as “an undesired or unintended 
effect of the ARV” to examples of symptoms such as diarrhoea, rash. dizziness, vomiting, 
bad dreams and headaches. Most of the respondents described examples of side effects rather 
than a technical definition of a side effect. The pharmacological definition of a „side effect” 
was only provided by clinical staff whereas the examples of side effects were known by all 
categories of staff. The basic, common side effects were described by all participants with 
none of the  participant referring to a medium or late side effect. This tells us that there is 
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more familiarity and an easier recall of the early than the medium or late side effects of 
ARVs. The common side effects are also the more experienced and common side effects that 
patients routinely complain about. 
 
Question 9: Have you been told about the side effects of ARVs? 
 
 
 
 
 
 
 
Figure   4. 8:   Number of participants vs.  the awareness of the side effects of ARVs  
The graph shows that all participants (100%) were told about the side effects of ARVS and 
this implies that all staff have the knowledge to inform patients and other staff members 
about the side effects of ARVs. 
 
Question 10: Who informed you about the side effects of ARVs? (More than 1 answer 
can be circled) 
Bar/Column Plot of Count of yes
Spreadsheet12 3v*6c
 Count of yes
36%
12%
32%
4%
12%
60%
Doctor
Nurse
Pharmacist
Pharmacist Assistant
Counsellor
Other
Question 10
0
2
4
6
8
10
12
14
16
 
Figure     4.9    :   Number of participants vs. the person/s who informed the participant  
                               about the side effects of ARVs 
The graph indicates that 36% of the respondents were informed by a doctor, 12% were 
informed by a nurse, 32% were informed by a Pharmacist, 4% were informed by a 
Histogram of Question 9
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Pharmacist Assistant, 12% were informed by a counsellor and 60% were informed by the 
lecturers at a university or college. The results show that most of the participants were 
informed about the side effects through formal training and education whereas other 
participants gained knowledge through practical in- service training sessions as well as the 
experiences of working with a doctor, pharmacist or nurse. The Pharmacist Assistant was the 
least involved in providing knowledge and information about the side effects to other 
participants. 
 
Question 11: Do you think that the side effects of ARVs are something serious? 
 
Histogram of Question 11
Spreadsheet9 in staff questionnaire.stw 80v*25c
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Figure   4. 10: Number of participants vs. the perception of the  seriousness of  
                        ARVs  
The results show that 60% of participants thought that side effects are a serious concern, 36% 
thought that side effects are very serious and 4% thought that the side effects are a little 
serious. None of the staff thought that side effects are not serious or nothing to worry about. 
This question was asked to establish the perception of the seriousness of side effects by staff  
as the perception of staff could influence the perception ofthe patients. 
 
Question 12: What do you think causes the side effects of ARVs? 
This was an open ended question and it was asked to assess the individuals understanding of 
the mechanism of action of the ARVs. The question elicited various responses. 
The responses ranged from “it‟s something that‟s in the medication”, “it‟s the weak response 
of the immune system “or “it‟s the toxicity of the ARVs”.   
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Generally most participants thought it was due to the new introduction of the ARVs to the 
body, which generated an undesired reaction and this was thought to be a side effect. 
The responses from the participants  indicate that the staff have knowledge about the action 
of the ARVs but there was difficulty amongst some participants in the understanding of the 
pharmacology and  the mechanism of action of the ARVs. There was no mention of the 
influence of drug-drug; drug-food, drug-chemical interactions .This carries significanceas it 
can contribute to a side effect and it needs to be considered when patients are counselled or 
when  ARV adherence levels are monitored. 
 
Question 13:   Do you think that the side effects of ARVs can be stopped or    
                          discontinued? 
 
Histogram of Question 13
Spreadsheet9 in staff questionnaire.stw 80v*25c
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Figure   4.  11   : Number of participants vs. the perception of the discontinuation of  
                             ARVs 
 
From the graph it is observed that 76% of the participants thought that side effects could be 
stopped or discontinued whereas 24% thought that the side effects of ARVs could not be 
stopped.      
In practise if patients complain about the side effects they are referred to a clinician who 
provides symptomatic treatment for the relief of the side effect or in severe cases the patient 
is switched to an alternative treatment regimen. 
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Question 14: How many side effects of ARVs can be stopped? 
Histogram of Question 14
Spreadsheet9 in staff questionnaire.stw 80v*25c
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Figure      4.12   : Number of participants vs. the knowledge of  stopping               
                              the side effects of ARVS 
This question was asked to understand the participants‟ knowledge of the length and duration 
of the side effects of ARVS. From the graph it is observed that 48% of the participants said 
that most of the side effects can be stopped, 40% said some of them can be stopped, 8% said 
all of them can be stopped and 4 % said none of them can be stopped. Most of the 
participants thought that most of the side effects could be stopped, as  transient side effects 
stop after 3-4 weeks of initiating treatment with ARVs. The medium and late side effects of 
ARVs are more challenging and complicated to stop and the clinician will weigh up the 
benefits of the drug in comparison to the side effect in order to derive the best clinical 
outcome for the patient.  
 
Question 15: Do you think that side effects can change over time with the treatment of  
                      ARVs? 
 
Histogram of Question 15
Spreadsheet9 in staff questionnaire.stw 80v*25c
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Figure      4.13.   : Number of participants vs. knowledge of the change of                                
                               side  effects of ARVs over time 
Stellenbosch University  http://scholar.sun.ac.za
 42 
 
The graph indicates that 84% of the participants thought that side effects could change over 
time, 12% said that side effects could not change over time and 4% did not know whether the 
side effects could change over time.The results indicate that the participants are awarethat the 
side effects could change. This knowledge was based on their practical experiences of the  
side effects in patients and the knowledge of the medium and late side effects of ARVs in 
HIV patients. 
 
Question 16:  Did you receive training on the side effects of ARVs? 
Histogram of Question 16
Spreadsheet9 in staff questionnaire.stw 80v*25c
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Figure    4. 14  : Number of participants vs. completion of training 
It is observed that76% of the participants were trained on the side effects of ARVs whereas 
24% of participants said that they were not trained on the side effects of ARVs. 
The staff were provided with formal or informal service training on the side effects of ARVs. 
It is critical that 100% of staff are trained on the side effects of ARVs. 
 
Question 17: When and where did you receive training about the side effects of ARVs? 
Please explain. 
This was an open ended question and it elicited various responses. 
The question was included to validate the answer to question 16 above. 
Participants were trained at university, at formal workshopsprovided by external consultants 
or at “in- service” training sessions” at the clinic. Only one participant provided a date when 
he received training. 
 . 
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C. QUESTIONS ON PERCEPTION  
 
Question 18:  Do you think the side effects of ARVs are something good or bad? 
Histogram of Question 18
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Figure    4.15    :  Number of participants vs. the perception of the bad or good side  
                              effects of ARVs 
The graph shows that 68% of the participants thought that side effects are bad, 20% thought 
side effects are very bad, 8% thought the side effects are something very good and 4 % of the 
participants said that side effects are not good or bad. None of the  participants thought that 
side effects are something good that happens to you. Most staff thought that a side effect is 
something bad that happens and this is the „normal‟ theoretical perception, but the above 
results also show that two participants thought a side effect is something very good. The 
participants explained  this perception that a side effect is something good or very good as  
the clinician is then able to prescribe alternative drugs to customise the regimen or “suit “the 
patient. 
 
Question 19:  Is it difficult to understand the side effects of ARVs? 
Histogram of Question 19
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Figure    4. 16: Number of participants vs. the difficulty in understanding the side  
                            effects of ARVs 
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 It is observed that 80% of the participants said it was not difficult to understand the side 
effects and20% of the participants said that it was difficult for them to understand the side 
effects of ARVs.Most staff said that it not difficult to understand the side effects of ARVs 
and this was because the side effect is interpreted in „layman‟s terms and not using scientific 
or clinical terminology.  
This also implies that staff need to understand the actions of the ARVS in the body in order to 
understand the side effects especially if a side effect cannot be translated into non-scientific 
terms. 
 
Question 20: If yes (in number 19 above) please explain: 
From the results 80% of the participants said it was not difficult to understand the side effects 
of ARVs but five participants said it was difficult because of the pharmacology and 
mechanisms of action of the ARVS. One participant said it was difficult because of the 
different treatment regimens of ARVs which is confusing. This indicates that we need to look 
at different ways in training staff about the side effects so that all staff can understand the 
terminology and applications of the side effects of ARVs. 
 
Question 21: Do you think patients know about the side effects of ARVs?  
Histogram of Question 21
Spreadsheet9 in staff questionnaire.stw 80v*25c
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Figure 4.17    :  Number of participants vs. the perception of other patients’ knowledge  
                           on the side effects of ARVs 
The results show that 8 % of participants thought that all patients know about the side effects 
of ARVs, 28% said that most of them know and 64% said that only some of the patients 
know about the side effects. The highest percentage of respondents thought that only some 
patients know about the side effects which indicates that staff needto improve the knowledge 
and communication of the side effects to all patients In practise one would expect all of the 
patients to know about the side effects of ARVs as all patients are counselled about the side 
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effects before starting ARVs. These low results indicate that staff need to use different 
interventions and approaches to communicate more effectively to patients and to improve this 
perception.   
 
Question 22: Do you think that patients must be told about the side effects of ARVs? 
 
 
 
Figure    4. 18   :  Number of participants vs. the perception of patient knowledge on the  
side effects  of  ARVs  
The results show that 100% of the participants (i.e. all staff) think that patients must be 
informed  about the side effects of ARVs. This result is an important finding and contrary to 
the introductory statements in chapter 1 of this research study. 
 
Question 23: Do you think that patients look for the side effects of ARVs or any changes 
in their body? 
Histogram of Question 23
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Figure 4.19Number of participants vs. the perception of the application of patients’  
                        knowledge about the side effects of ARVs 
 
Histogram of Question 22
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The graph shows that 52% of the participants thought that patients look for the side effects or 
any changes in their bodies whereas 24% said that they do not know if patients look for the 
side effects or any changes in their bodies and 24% did not think that patients look for any 
side effects or changes in their bodies.There is an equal distribution of negative responses to 
this question but most participants thought that patients could apply the knowledge of the 
effects to themselves. Staff should encourage all patients to look for the side effects or 
changes in their bodies so that their condition could be managed more optimally. 
 
Question 24: Do you think that the patient’s knowledge about side effects is linked to  
adherence? 
 
Histogram of Question 24
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Figure 4.  20     : Number of participants vs. the link to the adherence of ARVs 
 
From the responses it is observed that 80% of the participants think that the patients‟ 
knowledge of the side effects is linked to adherence, 16% thought that it is not linked to 
adherence and 4% did not know if there was any linkage of the patients knowledge of the 
side effects and adherence. This implies that if patients are not knowledgeable about the side 
effects it could lead to defaulting and non adherence to treatment. Adherence is an important 
element in the management of patients and this emphasizes the need for patients to 
understand their ARVs and treatment regimens.  
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Question 25:  When do you think patients must be told about the side effects of ARVs?    
                        (More than 1 answer can be circled) 
Bar/Column Plot of Count of yes
Spreadsheet13 3v*9c
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Figure   4.  21   : Number of participants vs. the frequency of telling patients about the  
                            side effects of ARVs 
The results show that 60% of responses indicate that patients must be told about the side 
effects before starting ARVs, 36% said that patients must be told when ARVs are initiated, 
24% said that patients must be told with every visit and 4 % said that patients must be told 
when there is a regimen or a dosage change. None of the participants indicated that patients 
should be told after 1, 3, 6 or 12 months (1 year) of initiation. T his perception is important as 
it influences the knowledge of patients and it also provides an explanation of the current 
practices that staff follow at the clinic. 
 
Question 26.  Do you think staff members at this facility know about the side effects of  
                     ARVs? 
Histogram of Question 26
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Figure    4.22   :  Number of participants vs. the perception of the side effects of ARVS   
                            amongst other staff members 
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This question was asked to gauge the communication and practices followed at the facility as 
staff interact with patients and other staff members 
From the graph it is observed that  24% of participants said that all of them know,44% said 
most of them know, 28% said some of them know and 4 % did not know if staff knew about 
the side effects of ARVs. A  low percentage of staff think that all of their colleagues know 
about the side effects of ARVs and to correct this perception, more training needs to be 
provided staff at the clinics.44% of staff think that most of the colleagues at facilities know 
about the side effects of ARVs. This implies that  for 100% of staff to know about the side 
effects ,more training needs to be provided to the staff.   
 
Question 27: Who do you think must inform patients about the side effectsof  
                      ARVs? (More than 1 response can be circled) 
Bar/Column Plot of Count of yes
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Figure  4.23  : Number of participants vs. the person/s responsible for informing  
                          patients about  the side effects of ARVs 
 
The results show that 92% of respondents thought that the  pharmacist must inform patients 
about the side effects of ARVs. ,84 % thought it was the counsellors‟ resposnsibility,72% 
said it was the doctor and nurses‟ responsibility to inform patients and 52% thought it was the 
pharmacist assistants‟ responsibility. 
 The respondents thought that the Pharmacist had the highest percentage and  responsibility to 
inform patients about the side effects of ARVS although all participants play a role in 
informing patients about the side effects of ARVs. In practice it was observed that the 
pharmacists were not counselling patients about the side effects of ARVs due to time 
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constraints and the huge patient numbers that are seen on a daily basis. Interventions are 
needed to correct the practices and  perceptions  of the role of the pharmacist, as well as the 
role of other staff members in finding the best practical and sustainable solution .  
 
Question 28.    Do you think there is enough time spent educating patients about the side  
                        effects of ARVs?   
Histogram of Question 28
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Figure  4.24  :   Number of participants vs. the perception of time spent educating  
                             patients about the side effects of ARVs 
 
The graph shows that 52% of participants thought that not enough time is spent educating 
patients about the side effects of ARVS,40%  of participants thought enough time was spent  
in educating patients about the side effects, and 8% did not know if enough time is spent 
educating patients about the side effects of ARVs.Thus result supports the response to 
question 26 because if  not enough time is being spent in educating patients about the side 
effects then not all of the patients will know about the side effects of ARVs. Time is an 
important element in the communication and education of patients   about their condition. An 
intervention is thus needed to spend more time educating patients about the side effects of 
ARVs.  
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D. QUESTIONS ON ATTITUDE 
 
Question 29:  Do you inform patients about the side effects of ARVs? 
Histogram of Question 29
Spreadsheet9 in staff questionnaire.stw 80v*25c
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Figure  4.25   :  Number of participants vs. the attitude of participants to inform  
                            patients about the side effects of ARVs 
It is observed that 44% of the participants said they inform patients about the side effects of 
ARVs all of the time,24% said  they inform patients most of the time,20% said they inform 
patients sometimes, 4 % do not inform patients and 8% of the results were invalid(unknown). 
The results indicate fewer than half of the participants inform the  patients all the time about 
the side effects of ARVs. It is expected that all  patients must be informed about the side 
effects of ARVS  and this means that staff need to find a practical solution  to inform all 
patients about the side effects of ARVS all the time. 
 
Question 30:    Do you tell them the same side effects each time they visit the 
                         Clinic /hospital? 
Histogram of Question 30
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Figure    4. 26: Number of participants vs. the provision of the same or different side  
                            effects by staff to patients 
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The results show that  64% of participants do not tell the patients about the same side effects 
every time they visit the facility,28 % tell patients about the same side effects every time they 
visit the clinic and 8% of the results were unknown (invalid ) .In practice this means that the 
participants  need to have a structured approach of  recording the side effects in the patients 
folder ,in order  for the patient and staff member to know what side effects were previously 
discussed with the patient. This was not standard practise at the clinics amongst all staff 
members. 
 
Question 31:  How many side effects do you tell them of each ARV? 
Histogram of Question 31
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Figure   4. 27   : Number of participants vs. the number of side effects provided to  
                            patients 
The results show that 24 % of the participants provide 2 side effects per ARV to the patients, 
24% of participants provide 4 side effects per ARV, 12% provide 3 side effects per ARV, 
12% provide 1 side effect per ARV, 20% provided an independent number based on the 
patients level of education and 8% of the participants responses were unknown (invalid). 
The graph shows an equal distribution between 2 and 4 side effects, as well as between 1 and 
3 side effects per ARV but most of the participants shared 2 or 4 side effects per ARV with 
patients. 
 
Question 32: How do you decide how many side effects you must tell the patient? 
This was an open ended question toprovide information how staff decides how many side 
effects to tell a patient. Most participants said that they explain the most common ones and 
the most experienced side effects that patients complain about. Some of the responses are 
described below: 
“If the patient has a reasonable understanding and asks questions, I explain as much as 
possible.” 
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“It‟s important to tell everything you know.” 
“I explain if the patients ask.” 
“I must have an understanding what regimen the patient is introduced to then I would decide 
to tell the patient. “ 
This question was asked to see whether a patient‟s individual need could be addressed. The 
results show that staff inform patients about the side effects of ARVs but they think that it 
depends on the individual‟s treatment regimen and the patients understanding of their 
condition. 
 
Question 33: Do you tell them the general or specific side effects of ARVs? 
Bar/Column Plot of Count of yes
Spreadsheet15 3v*3c
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Figure     4.28   :  Number of participants vs. informing patients about the general or  
                                specific side effects of ARVs  
The graph indicates that 48% of participants inform patients about the general side effects of 
ARVs, 48% inform patients about the specific side effects of ARVs and 8% of the responses 
were unknown (invalid).An equal distribution is observed between the provisions of general 
or specific side effects to patients. This means that in practice both the general and specific 
side effects are told to patients as in theory many of the side effects of the ARVs overlap. The 
specific side effects such as lipodystrophy are uniquely related to an ARV drug such as 
Stavudine tablets. 
 
Question 34:  When patients tell you their side effects what do you do? 
Histogram of Question 34
Spreadsheet9 in staff questionnaire.stw 80v*25c
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Figure 4.29: Number of participants vs. the response of staff in managing side effects 
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It is observed that 72% of the participants refer the patient to a doctor, 16% report the side 
effect, 4% of participants stop the ARVs and 8% of the responses were unknown (invalid).A 
low number of side effects are reported and this practice needs to be improved to an optimal 
and practical level of reporting as all side effects need to be reported. 
In practise when patients experience a side effect they are referred by the staff to a doctor. 
This implies that the doctor is one of the key role-players at wellness clinics and at ART sites. 
The results indicate that we expect the doctors to initiate and report the side effects of patients 
to MCC and the respective authorities. 
 
Question 35:     Do you report the side effects of ARVs? 
 
 
 
Fig   4. 30:Number of participants vs. the frequency of reporting side effects of ARVs 
 
The graph shows that 52% of the participants report the side effects all the time, 20% report it 
most of the time, 20% report it sometimes, 4% of participants never report it and 4 % of the 
responses were unknown (invalid).The results imply that only half of the participants report 
the side effects of the ARVS all of the time which is below the expectation that all side 
effects must be reported to the respective authorities.This shows that there is a need for an 
improvement on the reporting of the side effects or the process of reporting needs to be 
investigated to improve the current status of reporting in the province. 
 
 
 
 
Histogram of Question 35
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Question 36:     To whom do you report the side effects of ARVs? (More than 1reponse  
                           can be circled)  
Bar/Column Plot of Count of yes
Spreadsheet16 3v*8c
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Figure   4. 31: Number of participants vs. the reporting of the side effects to a person/s 
From the graph the responses indicate that 48% of the respondents report the side effects to a 
doctor, 32% report it to the Medicines Control Council, 20% report it to a Pharmacist, 16% 
report it to a nurse, and 8% to a counsellor and 0% report it to a Pharmacist Assistant. This 
shows that the doctor has the greatest responsibility to report the side effects of ARVs. The 
low percentage of reporting from nurses and Pharmacists requires further investigation. 
 
Question 37: Do you want to know more aboutthe side effects of ARVs? 
Histogram of Question 37
Spreadsheet9 80v*25c
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Figure   4. 32   :  Number of participants vs. the need for more knowledge on the side  
                             effects of ARVs 
From the graph it is observed that 88% of participants want to know more about the side 
effects of ARVS,8% do not want to know more about the side effects of ARVs and 4% did 
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not know if they wanted to know more about the side effects of ARVs. This indicates that 
there is a need for more awareness and training on the side effects of ARVs. 
 
Question 38:  Do you ask questions about the side effects of ARVs? 
Histogram of Question 38
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Figure 4.33: Number of participants vs. the frequency of asking questions about the  
                        side effects of ARVs 
The results show that  32% of the  participants ask questions about the side effects of ARVs 
all the time,28%  of the participants ask questions sometimes,24% ask questions  about the 
side effects most of the time, 8%  of participants never ask questions and 8 % of the 
responses were unknown(invalid). 
Learning is gained through asking questions to patients and staff and the low results could be 
due to the complexity in understanding the pharmacology of the ARVs and the side effects. 
This indicates that training must be provided to staff to improve their knowledge on the side 
effects of ARVs.   
 
Question 39: Do you read more about the side effects of ARVs? 
Histogram of Question 39
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Figure   4.34:  Number of participant vs. the frequency of reading about the side effects  
                            of ARVs 
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The graph shows that 24% of the participants read about the side effects of ARVs  all the 
time,32% read  about the side effects of ARVs sometimes,,28% read about the side effects   
most of the time, 4% „never „read  about the side effect of ARVs and 12%  of the responses 
were unknown(invalid). Staff should be encouraged to read more about the side effects of 
ARVs so that they are „up to date „and knowledgeable about the side effects of ARVs. In 
practise the provision of pamphlets, brochures and posters at clinics would create an 
enviroment to enable staff to read more about the side effects of ARVs. 
 
Question 40:    What do you think will assist patients to know more about the side?       
                          effects of ARVs? (More than 1 can be circled) 
Bar/Column Plot of Count of yes
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Figure     4.35: Number of participants vs. aids to support patient knowledge in  
                            understanding the side effects of ARVS 
It is observed that 68% of respondents thought that counselling was necesssary, 60% 
suggested health talks,48% suggested support groups, 32 % suggested the use of pamphlets, 
20% suggested the use of posters, 8% suggested the use of patient diaries and 4% suggested a 
combination of all these measures toimprove the patients‟ knowledge and understanding of 
the side effects of ARVs. This indicates that counselling, support groups and health talks 
should be prioritised to assist and provide patients with more knowledge about the side 
effects of ARVs. The staff thought that pamphlets  and posters are useful  but it  ranked  the 
used of reading materials lower than the use of counselling, health talks and support groups 
as the staff routinely have to interact with patients with low education levels. These 
suggestions are critical interventions that are needed at the wellness clinics. 
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Question 41: Do you have any suggestions how the clinic/hospital can improve its 
services so that staff know and understand about the side effects of ARVs? 
 This was an open ended question and it was asked additionally to question 40 to obtain a 
wider source of responses. Most participants suggested that more training should be offered. 
The participants also suggested the following: 
“Ongoing in-service trainings and workshops” 
“More workshops after new research studies” 
“Everyone should start being more involved in HIV and AIDS” 
“By using every tool available and making full time provision” 
“Increase time for health talks and make pamphlets in addition to counselling” 
“Improve staff shortages” 
“Make a delegated person responsible to deal exclusively with the side effects in counselling    
  patients” 
“Have patient diaries, pamphlets, posters and proper tracking systems” 
“Develop a DVD and play this to patients during counselling and support group sessions” 
 The results of this question supports the results of question 40 (above).It was also suggested 
that the number of staff  at the wellness clinics need to be increased and staff need to be more 
supported in their respective roles. 
 
4.2BRESULTS FROM THE PATIENT QUESTIONNAIRES  
 
The proposed sample population size was 60 HIV patients (in total) but 62 patients 
participated in the study.  
The response rate for participation in the study is 103% with N = 62. 
 
Table   4.3  :  Participation of total HIV patients in the research study(N=62) 
Total participants intended to 
be part of the study 
Total number participants in 
study 
Response rate (%) 
60 patients 62 patients (62/60) x 100%  = 103% 
response rate 
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Table  4.4  :  Participation of  HIV patients per facility and per gender   
 Patients participating(N = 62) Percentage 
participation 
KHC patients 7 (7/62) = 11.29 % 
GDH patients 55 (55/62) = 88.71% 
Total patients  62 100% 
 
The results of the patient questionnaires are now discussed with a simplified analysis of the 
result included under each question and graph. 
 
A. GENERAL QUESTIONS 
 
Question 1: Age of participants                 . 
Histogram of Q1 age
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Figure 4.36    :  Number of participants vs. age 
 
The graph shows that 44% of the participants were in the 30-39 year old age group, 37 % 
were in the 40-49 year old age group, 15% were in the 20-29 year old age group, 3% were  in 
the 50-59 year old age group and 2%(1 participant) was in the 15-19 year old age group. This 
participant was above 18 years of age in order to be included in the study.The graph 
presented the highest distribution of patients between the 30-39 and 40-49 year old age 
groups. This appears to be in line with the results of the national antenatal survey (NDOH, 
2011) that shows the highest HIV prevalence amongst femalesin the 30-34 year old age 
group.   Age is an important element of any analysis as it carries significance in the approach, 
culture and manner of communication between person to person/s and health worker to 
patient/s.  
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Question 2: Gender of participants 
Histogram of Q2 gender
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Figure 4.37:  Number of participants vs. gender      . 
From the graph it is observed that66% of the participants in the study were female and 34% 
were male participants which could signify that there are more females than males attending 
the wellness clinics. This result is in line with the trend that more females than males are 
initiated on ART within the CCMT program in the province. (CCMT data, 2012)      
 
Question 3: Highest Education level 
Histogram of Q3 education
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Figure 4.38   : Number of participants vs. the highest level of education 
From the graph it is observed that only  40% of the participants had a grade 12 (standard 
10)education level, with 6% of  the participants having an education level of grade 7(standard 
5)and 53% of the participants had another education level. The other education levels 
included grades 2,3,6,8,810 and 11.The lowest level of education was grade 2.The education 
level of the participants is important as it enables the researcher to understand and relate the 
results to other questions in the study. Education is an important concept in the management 
of HIV patientsand their adherence to treatment. 
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B. QUESTIONS ON KNOWLEDGE  
 
Question 4:   Can HIV be cured? 
Histogram of Question 4
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Figure 4.39   : Number of participants vs. responses to the question”Can HIV be  
                          cured?” 
The graph shows that 47% of the participants said that HIV can be cured and 53% said that 
HIV cannot be cured. There was a higher percentage of patients that think that HIV cannot be 
cured. This perception is important with regards to the management and approach of the 
patients as it shows us their understanding of their condition in the management of HIV. The 
results do not show if the perceptions are related to the age group, gender or educational 
status of patients or whether the perceptions are related to the communication or practices at 
the facilities.  
 
Question 5: What treatment is provided at a clinic/hospital to a person with HIV? 
Bar/Column Plot of Count of yes
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Figure 4. 40:  Number of participants vs. knowledge of treatment at a clinic or hospital 
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The results indicate that 100% of the participants said that ARVS (and other medicines) are 
provided at the clinic or hospital to a person living with HIV. This shows that all the 
participants knew that ARVS (and other medicines) are provided at the clinic/hospital. and 
herbal or traditional medicines are not provided at the clinic or hospital. The participants 
were able to provide examples of other medicines which are routinely used by HIV patients 
such as Co-trimoxazole tablets®, TB medicines, hypertensive medicines and vitamin tablets. 
 
Question 6: Are you taking ARVs? 
Histogram of Question 6
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Figure 4.41    : Number of participants’ vs.  the usage of ARVs 
The results show that 100% of the participants are taking ARVs as part of their treatment. 
This implies that all patients have some awareness or familiarity of their medication by 
means of the „common‟ names, generic or trade names, dosage or the dosaging schedule or 
the side effects they have experienced.  
 
Question 7: How long have you been taking ARVs? 
Histogram of Question 7
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Figure   4.42: Number of participants’ vs.  duration of the participant on ARVs 
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This graph indicates that 16 patients are 0 - 1 year on ARVs, 6 patients are between 1- 2 years 
on ARVs, 4 patients are between 2- 3 years on ARVs, 10 patients are between 3-4 years on 
ARVs, 10 patients are between 4- 5 years on ARVs, 8 patients are between 5-6 years on 
ARVs, 4 patient are between 6-7 years on ARVs, 3 patients are between 7-8 years on ARVs 
and 1 patient is between 9-10 years on ARVs. There are no patients between 8-9 years on 
ARVs. 
The graph also shows the mean (average) number of years for all the participants on ARVs as 
3.7708 years (approximately 3.8 years or rounded to an average of 4 years).The median of the 
graph is 4.0 which means that 4.0 years is the midpoint of the graph in which half of the 
participants are below this point and the other half are above this point. This implies that half 
of the participants are graphically shown to the left or the right of this point of 4 years.25-
75% of all the participants fall within 1 to 6 years on treatment and all participants are 
represented in the 0 to 10 year period with no outliers depicted on the graph. The graph 
informs us that in this study the highest number of patients were under 1 year on ARVs. 
The length that a patient is on ARVs is important as it informs us of the patients‟ knowledge, 
understanding and their adherence to ARVs. It also is able to provide us with knowledge of 
the counselling practices at the facilities. It is expected that the patients with the least number 
of years on ARVs should be able to recall more side effects, as they would have more recent 
experiences of the side effects or they would remember the side effects from recent 
counselling sessions in comparison to the recall of the side effects in a patient that has been 4 
years on ARVs. The knowledge of the length of patients on ARVs is important as it could be 
used to guide staff in counselling patients more effectively on the side effects of ARVs. 
 
Question 8:   Do you know the names of your ARVs? 
Histogram of Question 8
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Figure   4.43   :  Number of participants’ vs.  knowledge of the names of ARVs 
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The results indicate that 71% of the participants knew all of the names of their ARVs, 11% 
knew most of the names of their ARVs, 5% knew some of the names of their ARVs and 13% 
knew none of the names of their ARVs. The graph has not been further analysed in terms of 
the length of treatment on ARVs vs. knowledge of the names of the ARVs or the education 
levels vs. knowledge of the names of their ARVs but the data that was collected show that the 
participants with no knowledge of the names of their ARVs either have a low education level 
(grades 1, 2, 8) or they are elderly patients in the 40-49, 50-59 year old groups or they are 
patients that are under 1 year on ARVs. The knowledge of the names of ARVs is important as 
it is a step that is used to measure the adherence of the patient to the treatment schedule and it 
enables the staff and the patient to identify the ARVs that could cause side effects in the 
patient. The results indicate that staff should encourage all patients to know the „names of 
their ARVs. 
 
Question 9:  How do you take your ARVs? Please explain. 
This was an open ended question and it generated various responses. 
All participants knew how to take their ARVs and they could describe to the data collector 
how many tablets they take in the morning and at night. Some participants were not familiar 
with the trade or common name of the ARVs but they could identify the ARVs from the pill 
packets or containers .This proves that the patients are counselled on the identification, 
dosage and names of their ARVs. 
 
Question 10: Are you taking other medicines or herbs or traditional mixtures with your  
                      ARVs? Please explain. 
 
 
Figure   4. 44   : Number of participants vs. use of other medicines, herbs or traditional  
                           mixtures with ARVs 
Histogram of Question 10
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The graph shows that 65% of participants are not using other medicines, herbs or traditional 
medicines with their ARVs. The results show that 35% of the participants were using 
additional medicines such as hypertensive drugs, TB medicines and prophylactic drugs (such 
as Co-trimoxazole® tablets).One participant said that he uses an herbal product to “cleanse” 
his blood. This question is important as patients need to be aware of the effects of other 
medicines with the use of ARVs, as it could induce a drug-drug or a drug –herb interaction 
which could result in a side effect. 
 
Question 11:Do you think it is important to take your ARVs as you are told at the  
                       clinic? 
 
Histogram of Question 11
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Figure    4.45    : Number of participants vs. the importance of taking ARVs as   
                             instructed by clinic staff 
 
From the responses 97% of the participants said it was important for them to take their 
ARVsasthey were instructed at the clinic and 3% said it was not important for them to take 
their ARVs as they were instructed at the clinic. The participants said that it was important 
for them to take their ARVs as they were instructed because it improved their condition and 
their quality of life. The two participants said that it was not always possible for them to take 
their ARVs at the recommended time and they would deviate from the instructions if it was 
not possible for them to take their ARVs at the time.They considered it more important not to 
miss a dose. than the exactness of the time when taking ARVs. 
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Question 12: When you take your ARVs do you follow the instructions exactly as you 
are told at the clinic? 
Histogram of Question 12
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Figure  4. 46       : Number of participants vs. the exactness of following instructions  
                                when taking ARVs 
 
The graph shows that  82% of the participants  take their ARVs exactly as they are told at the 
clinic all of the time and 18 % of participants  follow the instructions exactly as they are told 
at the clinic most of the time. This is important as patients need to understand the importance 
of adherence to ARVs for a longer quality of life. 
 
13:  Do you know what will happen if you stop taking your ARVs? (More than 1 answer 
can be ticked)  
 
 
Figure    4. 47   : Number of participants vs.  the  responses to the    
                             discontinuation of ARVs 
 
The results indicate that  61% of the respondents think that they could die, 60% of the 
respondents think that  they could develop AIDS, 27%  think that they could become resistant 
Bar/Column Plot of Count of yes
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to ARVS, 2% of participants think that nothing could happen and 2% did not know what will 
happen if they stop taking their ARVs. This shows that the participants knew that the 
discontinuation of their ARVs could lead to death or AIDS  but only 27% of the participants 
acknowledged the possibility of the resistance of ARVs. This is important as the defaulting of 
participants (possibly due to the side effects of ARVs )could result in a patient being resistant 
to ARVs . Staff should make patients more aware about theresistance of ARVs in order for 
them tounderstand their treatment and to manage their side effects. 
 
Question 14. Have you been told about the side effects (unwanted effects)   of ARVs? 
 
Histogram of Question 14
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Figure   4. 48    : Number of participants vs. the awareness of the side effects of ARVs 
 
The results show that 95% of participants were told about the  side effects of ARVs  with 5% 
of participants not aware of the side effects of ARVs. This indicates that it is  the practice at 
the clinics to inform patients about the side effects of ARVs. 
 
Question 15.   What is a side effect (unwanted effect) of an ARV? (Please explain) 
This was an open ended question and a variety of responses were obtained from the 
participants. This question was included validate the participantsunderstanding of a side 
effect. The patients could either describe  the experience of a side effect or they could provide 
an example of a side effect. 
The participants provided examples such as “rash, dizziness, runny stomach, loss of memory, 
black nails, headaches, dreams, weight gain,skin,flu,pimples,big shoulders and stomach, 
painful legs, feet, cramps, dark skin and big buttocks.” Most of the participants provided 
examples of side effects rather than a definition of a side effect and this was based on their 
own experiences or examples of side effects they were counselled on. The participants knew 
the common or basic side effects and  not one  participant provided an example of a medium 
or late side effect. This was observed  in the participants that were on ARVs for  5  to 9 years 
as well. Weight gain and lipodystrophy was not perceived as a side effect by any participant. 
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Question 16: Who informed you about the side effects (unwanted effects) ARVs? (More 
than 1 answer can be ticked) 
Bar/Column Plot of Count of yes
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Figure  4. 49   : Number of participants vs. persons who informed the participants of the     
                          side effects of ARVs 
The graph shows that 69% of the respondents were informed by a counsellor, 35% of the 
respondents were informed by a doctor, 35% were informed by a nurse, 0% were informed 
by a Pharmacist, 0% were informed by a Pharmacist assistant and 10% were informed by a 
combination of health providers such as a counsellor and /or a doctor and/or a nurse. This 
graph shows an equal distribution of responses between a doctor and a nurse which confirms 
the practice that patients are seen by an available doctor or nurse. The graph also indicates the 
important role of the counsellor and the perception of the low role of the Pharmacist in 
informing patients about the side effects of ARVs.   
 
Question 17:When do they tell you about the side effects (unwanted effects) of ARVs?                   
                      (More than one answer can be ticked here) 
Bar/Column Plot of Count of yes
Spreadsheet7 3v*5c
 Count of yes
92%
23%
6%
3%
0%
When you start ARVs
Every month
Never
Every 3 months
don’t know
Question 17
0
10
20
30
40
50
60
 
Figure  4. 50  : Number of participants vs. the time the  participants are told about the  
                           side effects of ARVs 
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The results show that 92% of the respondents were told about the side effects when they 
started  treatment on ARVs,23% of the respondents indicated they are told every month,6% 
of the respondents said they were never told about the side effects and 3% said they are told 
every 3 months. This indicates that most patients are  informed about  the side effects of 
ARVs when they are  initiated on ARVs .A low percentage of respondents indicated that they 
are informed monthly about the side effects of ARVs.  
 
Question 18: Do you think the side effects (unwanted effects) of ARVs are something 
good or something bad? 
 
Histogram of Question 18
Spreadsheet2 in pt questionnaire.stw 72v*62c
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Figure   4.51    : Number of participants vs. the perception of the good or bad side  
                            effects of  ARVs 
 
From the graph 23% of participants thought side effects are very bad,52% thought side 
effects are bad,5% did not think side effects are good or bad,16% thought that side effects are 
something good, 2 % thought it was very good and 3% did not know if side effects are good 
or bad. The graph shows that most of the participants think that side effects are something 
bad. A small percentage of  patients thought that side effects are something good or very 
good because the doctor is then able to understand and treat your condition as a „unique 
„case.  
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Question 19: Do you think that the side effects (unwanted effects) of ARVs are 
something serious or something not to worry about? 
 
Histogram of Question 19
Spreadsheet2 in pt questionnaire.stw 72v*62c
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Figure  4.52   : Number of participants vs. the seriousness of the side effects of ARVs 
The graph shows an equal distribution of  responses indicating that 26% of participants 
thought that side effects are something serious or 26% thought it was nothing to worry about, 
19% of the participants‟ perceived side effects as something not serious and 15 % of 
participants perceived a side effect as either something a little serious or something very 
serious. The perception of the degree of seriousness of a side effect of an ARV  by  patients is 
important as it can  inform staff how to manage the  patients with their side effects. 
 
Question 4.20: What do you think causes the side effects (unwanted effects) of ARVs? 
This was an open ended question. Most of the participants thought a side effect  was  caused 
because “it was the first time they used ARVs”. Other participants thought it was because of 
the ARV drug or chemical itself and “the ARV was fighting with the soldiers (immune 
system)” hence the response of a side effect. Examples of the responses of the causes include: 
“They don‟t take their tablets correctly” 
“They don‟t sleep enough and follow a healthy lifestyle 
“Worries” 
“Others don‟t accept their condition” 
“Body is getting healed” 
Most participants knew that the ARVs can cause  side effects in the body and they were 
aware that the „common‟ side effects are transient and temporary. 
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Question 21:   Do you think that the side effects (unwanted effects) of ARVs can be 
stopped or discontinued? 
Histogram of Question 21
Spreadsheet2 in pt questionnaire.stw 72v*62c
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Figure  4. 53   : Number of participants vs. the perception of discontinuation of ARVs 
The results show that 89% of participants thought that the side effects could be stopped and 
11% thought that side effects could not be stopped. Patients who experience side effects are  
routinely provided symptomatic treatment to stop the side effects or the clinician will 
prescribe an alternative drug(ARV) if the side effect is problematic to the patient. This 
question gauges the perception  and  knowledge of the patient on the early, medium and late 
side effects of ARVs . 
 
Question 22: How many side effects (unwanted effects) of ARVs can be stopped? 
Histogram of Question 22
Spreadsheet2 in pt questionnaire.stw 72v*62c
9/ 15%
12/ 19%
20/ 32%
18/ 29%
3/ 5%
None of them
Some of them
Most of them
All of them
I don’t know
Question 22
0
2
4
6
8
10
12
14
16
18
20
22
N
o
 o
f 
o
b
s
 
Figure   4. 54 : Number of participants vs. the number of side effects that can be  
                          stopped 
From the graph it shows that 32% of the participants think that  most of the side effects can 
be stopped, 29% think that all of them can be stopped, 19% think that some of them can be 
stopped,15% think that none of the side effects could be stopped and 5% did not know if the 
side effects can be stopped. There is no known theoretical answer to this question  and the  
perception (that most of the side effects could be stopped) was based on the patients‟ 
experience and treatment of their side effects or it was based on the  knowledge the patients 
acquired during the counselling sessions. 
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Question 23:   Do you think that side effects (unwanted effects) can change over time the 
longer you are on treatment with ARVs? 
Histogram of Question 23
Spreadsheet2 in pt questionnaire.stw 72v*62c
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Figure   4. 55    :  Number of  participants vs. the perception of the change of  side  
                              effects of ARVs over time 
From the graph it is observed that 60% of participants thought that side effects could change 
overtime, 24% did not think that ARVs could change over time and 16% did not know if side 
effects could change over time. There is no known answer to this question as it tests the 
perception of the participant against the prediction of side effects in elderly HIV patients.  
 
Question 24:Is it difficult for you to understand the side effects (unwanted effects) of  
ARVs? 
Histogram of Question 24
Spreadsheet2 in pt questionnaire.stw 72v*62c
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Figure 4.56   :  Number of participants vs. the difficulty in understanding the side  
                        effects  of ARVs 
The graph shows that 77 % of participants said that it was not difficult for them to understand 
the side effects whereas 23% of participants said that it was difficult for them to understand 
the side effects of ARVs. It is essential for the staff to use different approaches when 
counselling patients on the side effects so that all patients understand the side effects of 
ARVs. This could prevent the defaulting of patients on ARVs. 
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Question 25: If yes (in number 24 above) please explain: 
The participants provided various reasons why they found it difficult to understand the side 
effects of ARVs. Some of the reasons were as follows:  “Because of their understanding of 
HIV,” because “side effects are  the same for everybody”, “because you don‟t understand 
why and how it works” and “because of the long names”. 
It is essential that patients understand the side effects in order for them to be able to manage 
their condition.  
 
Question 26:   Do you look for the side effects (unwanted effects) of ARVs or any 
changes in your body when you take your ARVs? 
 
 
 
 
 
 
Figure  4. 57    : Number of participants vs. the physical observation of side effects in   
                            the  participants   
 
The graph indicates that 71% of the participants look for the side effects or physical changes 
in their bodies whereas 29% do not look for the side effects or physical changes in their 
bodies. The reason why participants do not look for the side effects or physical changes is 
unknown as it was not further explored. Possible reasons could include fear or the lack of 
knowledge in the understanding of the medium and late side effects of ARVs in the body. 
This implies that there could be an underreporting of the side effects of ARVs by the patients. 
 
 
 
Histogram of Question 26
Spreadsheet2 in pt questionnaire.stw 72v*62c
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Question 27: Are you told about the side (unwanted effects) of ARVs at every clinic 
visit? 
Histogram of Question 27
Spreadsheet2 in pt questionnaire.stw 72v*62c
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Figure 4.58   :     Number of participants vs. the provision of information regarding the  
                              side effects of ARVs 
From the responses it is noted that 27% of participants are told all the time and most of the 
time when they visit the clinic, 24% of participants said they are told sometimes and 21% 
said they are never told about the side effects when they visit the clinic every month. There is 
an equal distribution of responses between most of the time and all the time. This indicates 
that staff are informing the patients about the side effects of ARVs when they visit the clinic 
but it would be more effective if 100% of the patients could be  told monthly about the side 
effects of ARVs. 
 
Question 28:  Do they tell you about the same or different side effects (unwanted effects)  
every time you visit the clinic? 
 
 
 
Figure   4.59: Number of participants’ vs.  responses to the question    on the same or  
                           different side effects 
The results show that 52% of participants said that they are told about different side effects 
every time they visit the clinic whereas 47% of the participants said that they are told about 
the same side effects every time they visit the clinic and 2% did not know whether they are 
told about the same or different side effects every time they visit the clinic. It is important 
Histogram of Question 28
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that the staff inform the patients about different side effects when they visit the clinic in order 
for the patient to understand, expect and manage the possible side effects of the ARVs. 
 
Question 29: Do you think the staff at the clinic know about the side effects (unwanted 
effects) of ARVs? 
Histogram of Question 29
Spreadsheet2 in pt questionnaire.stw 72v*62c
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Figure  4.60    :   Number of participants vs. the knowledge of staff on the side effects of  
                            ARVs  
 
The graph shows the perception of patients about the knowledge of staff on the side effects of 
ARVs .Participants were  asked this question because in practise any available counsellor, 
nurse, pharmacist or doctor would consult with the individual patient. This implies that the 
patient has the experience of engaging with different staff members at the clinic. 
The results show that only 45% of the participants thought that all staff know about the side 
effects of ARVs, 40% said that most of them know and  15% said that some of the staff know 
about the side effects of ARVs. The results indicate that not 100% of staff know about the 
side effects of ARVs and an intervention is needed to address this perception. 
 
Question 30: Do you think that other HIV patients know about the side effects 
(unwanted effects) of ARVs? 
Histogram of Question 30
Spreadsheet2 in pt questionnaire.stw 72v*62c
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Figure     4. 61     : Number of participants vs. the perception of the knowledge of other       
                                patients on the side effects of ARVs 
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The results show  that 24% of the participants said that all of them know,31% said most of 
them know,42% said some of them know and 3% did not know about the knowledge of other 
patients. The highest percentage of the participants indicated that only some of them know, 
which indicates that an intervention is needed to address the practices and the knowledge of 
the patients so that 100% of  patients   know about the side effects of ARVs. 
 
C.QUESTIONS ON ATTITUDE 
 
Question 31: What do you do when you experience any side effect (unwanted effect) of  
the ARVs? 
Histogram of Question 31
Spreadsheet2 in pt questionnaire.stw 72v*62c
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Figure   4.62   : Number of participants vs. the responses to managing a side effect  
The results indicate that 84% of participants would not do anything (but continue with their 
ARVs), 3% of the participants would stop taking the specific ARV causing the problem, 2% 
would stop taking all the ARVs and 11% would continue with their ARVs and return to the 
clinic. This indicates that the participants are knowledgeable about  the management of a side 
effect as well as the practises that are  followed at the clinic. 
 
Question 32: Do you report the side effects (unwanted effects) of the ARVs? 
 
Histogram of Question 32
Spreadsheet2 in pt questionnaire.stw 72v*62c
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Figure  4.63    : Number of participants vs. the reporting of side effects  of ARVs   
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The graph indicates that 61% of participants would report a side effect all the time to the staff 
at the clinic,23% would report a side effect sometimes,11 % would report a side effect most 
of the time and 5% would not report a side effect to the clinic staff. It is expected of a1l 
participants to report any side effect to the staff at the clinic. The reasons for the  low 
reporting of the side effects should be further investigated. Staff should encourage all patients 
to report any side effect and  the staff should educate the patients about the significance of 
reporting the side effects of ARVs.  
 
Question 33: To whom do you report the side effects (unwanted effects) of the  
                     ARVs?(more than 1 answer can be ticked) 
 
Bar/Column Plot of Count of yes
Spreadsheet8 3v*8c
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Figure   4.64Number of participants vs. the reporting of the side effect to a person 
 
From the graph it  is observed that   74% of side effects are reported to a nurse, 48% of side 
effects are reported to a doctor, 13% of side effects are reported to a „family member‟, 8 % of 
side effects are reported to a friend, 2% are not reported to anybody and 18% of side effects 
are reported to the combination of a nurse, doctor and the counsellor. It is interesting to 
observe that 0% of the participants report a side effect to a Pharmacist or the Pharmacist 
Assistant .This suggests that an intervention is needed to involve the Pharmacist in the 
management of the side effects of the patient as the Pharmacist dispenses the ARVs to the 
patients at both the clinics. 
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Question 34:  Do you want to know more about the side effects (unwanted effects) of 
ARVs? 
Histogram of Question 34
Spreadsheet2 72v*62c
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Figure   4. 65      : Number of participants vs. the need for more knowledge on the side  
                                effects of ARVs 
 
The results show  that 89% of participants want to know more about the side effects of ARVs 
whereas 11% of participants do not want to know more about the side effects of ARVs. The 
participants who do not want more information on the side effects indicated  that they already 
know about the side effects of ARVs. This suggests that the same side effects were repeated 
to these participants. The participants who wanted to know more about the side effects 
showed more interest because they thought it was important for them to know and manage 
their condition.  
 
Question 35:  Do you ask questions about the side effects (unwanted effects) of ARVs at 
your clinic? 
 
 
Histogram of Question 35
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Figure  4.66    : Number of participants vs. the frequency of asking questions about the  
                           side effects of ARVs 
 
Stellenbosch University  http://scholar.sun.ac.za
 78 
 
The results show that 31% of participants ask questions on the side effects of ARVs most of 
the time ,10 % ask questions all the time,24% of participants ask questions sometimes,26% 
never ask questions on the side effects of ARVs and 10% do not know how to ask questions 
on the side effects of ARVs. The result that shows 26% of participants never ask questions 
could imply that patients are either not interested in the side effects or it could be that the side 
effect was something they expected( hence their weak response )or it could imply that 
patients do not understand the side effects. It is also noted that 10%  of the respondents did 
not know how to ask questions about the side effects of ARVs.This is important as 100 % of 
the patients must know how and where to ask about the side effects of ARVs at the clinic. 
This suggests that the practices and  communication  at the clinics need to be improved. 
 
Question 36: Do you read more about the side effects (unwanted effects) of ARVs? 
 
Histogram of Question 36
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Figure  4.67        : Number of participants vs. the frequency of reading about the side  
                              effects of ARVs 
 
The graph shows that 29% of the participants  read more  about the side effects of ARVs 
sometimes,21% read more about the side effects of ARVs most of the time.21% never read 
more about the side effects of ARVs,16% read about the side effects of ARVsall the time and 
13% of participants do not know where to get the information.The low results indicate that 
access to the information about the side effects of ARVs  is a challenge and the clinic should 
explore different approaches to avail information to the patients. 
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Question 37: What do you think will assist HIV patients to know more about the side 
effects (unwanted effects) of ARVs? (More than 1 can be ticked) 
Bar/Column Plot of Count of yes
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Figure  4. 68   : Number of participants vs. the use of different approaches to  inform  
                           patients about the  side effects of ARVs  
 
The results indicate that 74% of the respondents suggested the need for support groups, 55% 
of the respondents suggested the use of counselling, 21% of the respondents suggested the 
use of pamphlets, 15% of the respondents indicated the need for posters, 13% suggested the 
use of health talks and 6% of the respondents indicated the use of patient diaries. The support 
groups, counselling and pamphlets are the three priority suggestions that will assist other HIV 
patients to understand the side effects of ARVs. The face to face approach in support groups 
and counselling sessions appear to be more practical because of the  low education  levels of 
the patients.   
 
Question 38: How many side effects (unwanted effects) of each ARV do you think they 
must tell you about when you visit the clinic? 
Histogram of Question 38
Spreadsheet2 in pt questionnaire.stw 72v*62c
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Figure  4.69   : Number of participants vs. the requested number of side effects for  
                          patients 
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This question was asked to the participant to gauge the need of the participant for more 
knowledge about the side effects of ARVs. The results show that 35% want to know 4 side 
effects per ARV,23% want to know 1 side effect per Arv,18% want to know 3 side effects 
per ARV ,15% want to know 2 side effects per ARV,8% do not know how many side effects 
they would like to be told about and 2% do not want to know more about any side effects of 
ARVs.  
These results are important because it indicates that 35% of patients want to be told about as 
many side effects as possible  and  23% of participants want to be told about 1 side effect of 
every ARV. 
 
Question 39:  When must they tell you about the side effects (unwanted effects) of your 
ARVs? 
Histogram of Question 39
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Figure  4.70   : Number of participants  vs. the provision of information about the side  
                          effects of ARVs 
 
It is observed that  73% of participants want to be told every month about the side effects of 
ARVs,15%  of participants want  to be told every 2
nd
 month,8% want to be told every 3
rd
 
month,2% want to be told every 6 months and 3% never want to be told about the side effects 
of ARVs. These results imply that the staff  should inform the patients about the side effects 
of ARVs monthly , every 2 months or every 3 months depending on the need of the patient 
but the majority of patients would like to be told monthly about the side effects of ARVs. 
 
Question 40:  Do you have any suggestions how the clinic can improve its services so 
that all HIV patients know and understand the side effects (unwanted effects) of ARVs? 
This was an open ended question and the purpose of the question was  to generate responses 
additional to the responses provided in question 37 . 
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Most participants felt the suggestions in question 37 were sufficient. Other  responses 
included the following: 
“Give classes or talks on a Saturday to patients” 
“Tell them every month” 
“Clinic must help patients to accept their condition” 
“Health talks for patients or support groups” 
„They must recruit more people with HIV” 
“Get more staff at the clinic” 
“Give counselling, health talks” 
“Start a support group” 
The participants strongly suggested the need for support groups and health talks as they felt 
this would assist other patients in understanding the side effects of ARVs.  
 
4.3 Conclusion  
 
The main findings of the results of this study are discussed in the following chapter. 
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CHAPTER 5     FINDINGS OF THE STUDY 
 
5.1 Introduction 
This chapter provides  discussion around the results of the staff and patient questionnaires. 
Firstly the results and findings of the staff responses will be discussed, secondly the results 
and findings of the patient responses will be discussed and thereafter the results will be 
analysed within the theoretical context of this study.  
 
5.2 Limitations of the study 
The sampling sites were limited to facilities where the CCMT programme was in existence 
for a period longer than 3 years and the sampling site needed to have a doctor, pharmacist, a 
nurse and an adherence counsellor at the wellness clinic of the facility. 
The target population had to be adults of 18 years or older. This excluded paediatric patients 
and adolescent patients younger than 18 years of age.                 
 
5.3 Challenges of the study 
The period in which the data was collected (November to December) was a challenge as the 
clinics operated with minimal operational staff due to the staff either being involved in exams 
or on vacation. Stable patients at the wellness clinics were provided with two months‟ supply 
of ARVs from November due to the “scaling down” of activities for the vacation period in 
December/January. At KHC very few patients were booked for the clinic in December which 
explains the minimal participation by patients from KHC in the study. The data was collected 
by the data collector once a week at the clinics over a four  to eight hour period due to work 
obligations. 
 
5.4 The main findings from the responses of staff and patients 
5.4.1 Demographic analysis 
The demographic analysis shows that the largest age group of staff((59% of staff)  were 
between 20 and 29 years of age whereas the largest age group of patients(44% of patients) 
were between 30 and 39 years of age. This implies that at the clinics young staff have the 
responsibility of educating patients much older than themselves. More female participants 
(72% in staff and.66% in patients) than male participants (28% in staff and 34% in patients) 
participated in the study. The highest education level of the staff was at university level 
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whereas the highest education level of patients was grade 12(std.10) .The lowest education 
level amongst staff was grade 12(std 10) and grade 2 in respect of the patients. 
 
5.4.2 Knowledge  
All of the staff (100% of staff) said that HIV cannot be cured whereas only 53% of patients 
said that HIV cannot be cured. The reasons for this discrepancy amongst the patients requires 
further investigation. All of the staff (100%) knew the names, dosaging and frequency of 
ARVs whereas only 71% of patients knew the names of ARVs and 100% of patients knew 
the dosage and frequency of their ARVs. The generic names and trade names of ARVs 
confuse the patients ,as different suppliers have their unique product  trade name and as a 
result patients familiarise themselves  with the shape and colour of the  tablet rather than the 
name of the ARVs. All the patients who participated in the study were taking ARVs. The 
largest percentage of patients (25%) were less than 1 year on ARVs and the average number 
of years for all the patients of the study was 3.77 years. The staff were able to provide a 
clinical definition and examples of side effects whereas the patients were only able to 
describe examples of the side effects of ARVs such as diarrhoea, headaches, nightmares, 
painful legs or feet, big buttocks. It was also found that the examples that the patients 
provided coincided with the examples which the staff described. All staff (100%) were 
informed about the side effects of ARVs whereas only 95 % of patients said they were 
informed about the side effects of ARVs.  
 
The study showed that the key persons who informed staff about the side effects  were the 
lecturers at university(60%),the doctor(36%),the nurse(12%),the pharmacist(32%) and  the 
counsellor(12%) whereas in the group of patients the key persons who informed them about 
the side effects were the counsellor(69%),the doctor(35%),the nurse(35%) or a combination 
of the counsellor and/or doctor and/or nurse(10%). When the participants were asked about 
the “seriousness” of the side effects of ARVs, 60% of staff thought that side effects are 
serious, 36% thought it is very serious and 4 % thought it is a little serious. None of the staff 
thought that side effects are nothing to worry about or that it is not serious. In the group of 
patients, 26% thought that side effects are serious, 15% thought that it is very serious, 15% 
thought it is a little serious, 19% thought it is not serious and 26% thought it is nothing to 
worry about. 
The patients were asked if they were using herbs, traditional mixtures or other medicines with 
their ARVs and 35% of patients were using other medicines such as TB drugs, hypertensive 
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drugs, prophylactic treatment such as Co-trimoxazole® or Isoniazid tablets® and 1 patient 
was using Stomata ® mixture to “cleanse” his blood. 
When taking their ARVs, 97% of the patients thought that it was important to follow the 
instructions of the healthcare workers but only 82% of the patients followed the exact 
instructions (in terms of dosage and timing) of the healthcare workers all the time and 18% 
followed the exact instructions most of the time. In the group of participants of staff, 80% 
thought that the knowledge of side effects in patients is linked to adherence, 16% did not 
think that there was a linkage and 4 % did not know if the knowledge of side effects in 
patients is linked to adherence. When patients were asked what could happen if they stopped 
their ARVs, 61%  said that they could die if they stopped their ARVs,60% said they could 
develop AIDS, 27% said they could become resistant to ARVs,2 % thought that nothing will 
happen and 2% did  not know what could happen to them. The staff thought that the main 
reasons for the cause of a side effect was the introduction of the ARV to the body, the 
toxicity of the drug and the weak response of the immune system to the ARV. The patients 
thought that the side effect was caused by the „soldiers‟ fighting with the ARV in the body, it 
was because the patient was not adhering to the treatment regimen or they were not following 
a healthy lifestyle.  
 
The question was asked whether the side effects of ARVs could be stopped or discontinued 
and 76% of staff said it could be stopped with 24%  saying that it cannot be stopped. In the 
group of patients 89% said it could be stopped and 11% said it could not be stopped. In the 
group of  staff participants , 48% of staff said that most of the side effects could be stopped, 
40% said that some of them could be stopped, 4% said none of them could be stopped and 
8% said that all the side effects could be stopped. In the group of  patients ,32% thought that 
most of the side effects could be stopped,19% said some of them could be stopped,15% 
thought that none of them could be stopped,29% said all of them could be stopped and 5% 
did not know if the side effects could be stopped. The question was asked whether side 
effects could change over time and the results show that 84% of staff said it could change, 
12% said that it could not change and 4 % did not know if it could change ,whereas in the 
group of patients  60% said that it could change, 24% said  that it could not change and 16% 
did not know if the side effects could change over time. 
It was also observed that only 76% of the staff were trained  on the  side effects of ARVs. 
From the responses amongst staff, 24% of the respondents indicated that all staff know about 
the side effects of ARVs, 44% of the respondents said most of them know, 28% said some of 
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them know and 4% did not know if  staff were knowledgeable about the side effects of 
ARVs. In the responses from patients, 45 % of the respondents thought that all of the staff 
know about the side effects, 40%  thought that most of them know and 15% said that some of 
them know about the side effects of ARVs.  
 
5.4.3 Perception 
Amongst the group of participants of staff ,68% of staff thought that side effects are 
something bad,28% thought that it is  very bad,8 % thought it was very good and 4% did not 
know if it was good or bad. Amongst the group of  patients , 52% thought that that side 
effects are bad,23% said it was very bad,2% thought it was very good,16% thought it was 
good and 3% did not know if it was good or bad. It was observed that the participants (80% 
of staff vs. 77% of patients) did not think it was difficult to understand the side effects of 
ARVs. The difficulty that staff experienced was in understanding the mechanism of action 
and the pharmacology of the ARVs in the body whereas in the case of the patients, the side 
effects are explained  in a simple „layman‟s‟ language. All staff (100%) thought it is 
necessary to inform  patients about the side effects of ARVs but the results show that only 8 
% of staff thought that all the patients know about the side effects of ARVs, 28% thought that 
most of them know and 64% thought that some of the patients know about the side effects of 
ARVs. The responses from the patients indicated that 24 % thought that all patients know 
about the side effects, 31% thought that most of them know, 42% said some of them know 
and 3% did not know if other patients know about the side effects of ARVs. In gauging the 
application of knowledge about the side effects of ARVs, 71% of patients said that they look 
for any physical changes in their bodies or any side effects and 29% said they do not look for 
any signs or symptoms of side effects of ARVs. The  responses from staff indicate that 52% 
of staff think that patients look for side effects or changes in their bodies, 24% of staff think 
that patients do not look for any signs or symptoms and 24% did not know if patients looked 
for the side effects or physical changes in their bodies.   
 
It was necessary to know the practices of informing patients about the side effects of ARVs. 
Amongst the staff, 60% of staff  thought that patients must be informed about the side effects 
of ARVs before starting treatment, 36% thought that patients must be informed when they 
start ARVs, 24% said patients must be informed with every clinic visit and 0% thought that 
patients must be informed at 1 or 3 or 6 or 12 months after initiation of ARVs. With regards 
to the patients 73% want to be informed monthly, 15% want to be informed every 2
nd
 month, 
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8% every 3 months, 2% every 6 months and 3% never want to be informedabout the side 
effects of ARVs. This gap in results between the staff and patients is an important finding to 
address the knowledge of the side effects in patients. From the responses of the participants, 
the staff thought  that the responsibility of informing patients about the side effects of ARVs 
is a responsibility  of  the pharmacist(92%), counsellor(84%), doctor(72%), nurse(72%) and 
the Pharmacist Assistant(52%). In practise, the patients said that they were informed by the 
counsellor(69%),doctor(35%),nurse(35%),0%(Pharmacist) and 0%(Pharmacist 
Assistant).The  results from the respondents indicated that 57% of staff thought that not  
enough time is spent educating patients about the side effects,40% said enough time is spent 
educating patients and 8% of the responses were invalid. 
 
5.4.4 Attitude 
The attitudes of staff and patients towards the side effects of ARVs were also assessed as part 
of this study. The results show that 44% of the staff inform  the patients about the side effects 
of ARVs all the time, 24% inform patients most of the time, 20% inform patients sometimes, 
4% do not inform patients and 8% did not respond to the question. In practice, 27% of the 
patients said they were informed about the side effects all the time, 27% were informed most 
of the time they visit the clinic, 24% were informed sometimes and 2% were never informed 
about the side effects of ARVs. It was also found that 24% of staff tell patients 2 or 4 side 
effects per ARV, 12% tell patients 1 or 3 side effects per ARV, 20% tell patients an 
independent number of side effects depending on the patients‟ understanding, adherence and 
education and 8% provided no responses to the question. In the group of patients it was 
shown that 35% of patients wanted to know 4 side effects of each ARV, 23% wanted to know 
1 side effect, 15% wanted to know 2 side effects per ARV, 18% wanted to know 3 side 
effects per ARV, 2 % did not want to know any side effects and 8% did not know how many 
side effects per ARV they must be told. The results to the question shows a gap in the results 
between the staff and the patients. 
Another  finding  shows  that 48% of staff inform patients about the general side effects of  
the ARVS ,28% tell them the specific side effects of ARVs and  8% of the responses were 
invalid , whereas 47% of the patients said that they were informed  about the same side 
effects ,52% said they are informed of different side effects  and 2% did not know whether 
they are informed of the same or different side effects every time they visit the clinic. 
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When patients experience a side effect  72% of the staff will refer the patient to a doctor, 16% 
will report the side effect to an authority, 4 % will stop the ARVs and 8 % of the responses 
were invalid. In the group of patients, 84% of patients said if they experienced a side effect 
they would continue with their ARVs and not do anything, 2% will stop their ARVs, and 
11% will return to the clinic the next day and continue to take their ARVs. The staff  
responses indicate  that 52% of staff will report a side effect all the time, 20% will report it 
most of the time, 4% would never report it and 4% of the responses were unknown. In the 
group of patients it was observed that 61% of patients report the side effects all the time,23% 
report it sometimes,11% report it most of the time  and 5% do not report any side effect. 
Amongst the staff it was found that 48% of staff will report the side effect to a doctor, 32% 
will report it to the MCC, 20% will report it to a pharmacist, and 16% will report it to a nurse, 
8% to a counsellor and 0% to a Pharmacist Assistant. The group of patients  indicated that 
0% of patients will report a side effect to the Pharmacist,74% will report it to a nurse,48% 
will report it to a doctor,12% will report it to a family member,8% will report it to a 
friend,2% wil not report it to anyone and 18% will report it to the combination of doctor 
and/or nurse and /or a counsellor. The participants (88% in staff vs. 89% in patients) wanted 
to know more about the side effects of ARVs, .It was also shown that the participants read up 
most of the time (28% in staff vs. 21% in patients) or sometimes (32% in staff v.29% in 
patients).Additional results  show that the participants asked questions all the time (32% in 
staff vs. 10% in patients) or sometimes (28% in staff vs. 24% in patients).about the side 
effects of ARVs. In the last question the staff and patients provided suggestions to improve 
the knowledge  about the side effects of ARVs in other patients.. Amongst the group of staff,  
68% of staff suggested counselling, 60% suggested the use of health talks and 48% suggested 
the use of support groups to improve patient knowledge. In the group of patients,  74% of 
patients suggested support groups, 55% of staff suggested counselling, 21% suggested 
pamphlets.15% suggested the use of posters, 13% suggested health talks and 6% suggested 
the use of patient diaries to improve patient knowledge about the side effects of ARVs. Other 
suggestions from the staff and patients  includes the use of Saturday classes for patients, 
training for staff, increasing the staff complement at the clinics, having a delegated person to 
deal with the side effects of ARVs and also the use of educational materials such as DVDs on 
the counselling of the side effects of ARVs. It was also suggested that additional people with 
HIV be recruited at clinics ,as the clinics need to assist patients to accept their HIV status as a 
key priority. 
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5.5 An overview of the results 
The results were graphically presented as total groups of participants for staff and for patients 
because of the small number of participants per facility. This made it difficult to compare the 
different variables and results between the two facilities (KHC and GDH ) and this resulted in 
the analysis of the  total populations of staff and patients .  
The small sample size also makes it difficult to generalise the results of this study to a larger 
population size in the general population.    
 The findings of this study support the view of previous studies that recommend the pivotal 
role of the Pharmacist in counselling patients about the side effects of ARVs. The staff of the 
wellness clinics prepare and encourage patients to manage their side effects and this supports 
the study of Bartlett (2002). 
This study also supports the study by Agu  et al (2012) as patients at the wellness clinics are 
knowledgeable about the side effects of ARVs and they have a positive attitude with the 
reporting of ARVs.    
This refutes previous studies that argue that patients do not want to know about the side 
effects. The attitude of staff with regards to the reporting of side effects can be improved as 
this will encourage more pharmacists‟ and other role-players to become more involved in the 
reporting of  the side effects. The need for more involvement of the pharmacists in the 
management of the side effects correspond with the views of Matheson  et al (1999). 
The low result of the involvement of pharmacists at the clinics correspond with the findings 
of Fritsch  et al (1997).The suggestion of the use of a videotape to counsel and inform 
patients is supported by the study of Wong  et al (2006).In the study by Hoang et al (2011), 
38% of patients were concerned about the side effects of ARVs. The results of this study 
similarly support the study of Hoang et al (2011). 
The study that was conducted by Ruud et al (2012) in the Eastern Cape produced similar 
findings to the results of this study .The health providers also experienced challenges with 
training, communication and pharmacovigilance. Our study did not include poverty as a 
challenge as this was not measured in the study. This study could not support the findings of 
Nachega et al (2012) as the adherence levels of the patients were not measured quantitatively.    
 
5.6 Conclusion 
The findings and analysis of the results of this study provides us with a baselinereport on the 
practises at the wellness clinics. In the next chapter, recommendations are discussed to 
improve the practices at the wellness clinics.. 
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CHAPTER 6    RECOMMENDATIONS 
 
6.1 Introduction 
One of the objectives of this study was to improve the current practices at KHC and GDH. 
These interventions have been recommended to produce a more positive change to the 
current operations. Combinations of interventions are recommended rather than following 
one single approach .In doing so, it aims to reinforce, sustain and extend the impact of the 
interventions. 
 
6.2 Recommendations 
It is recommended that the wellness clinics introduce and implement a combination of these 
interventions as a project and  in a phased approach to  improve the quality of service s and 
care of the patients. 
The strategic interventions that are proposed are mainly educational interventions, 
administrative interventions and regulatory interventions. 
 
The educational interventions can be introduced to the staff members using various 
approaches such as scheduled training programmes, workshops and staff meetings. Printed 
materials such as posters, pamphlets, package inserts, patient information leaflets and 
brochures should be made available for  staff and patients. The wellness clinics should 
consider retrieving journals form the Kimberley Hospital Medicines Resource Centre on a 
monthly  basis to motivate staff to read more about HIV and medicines .The display of 
quarterly indicators at the facility on the monitoring of the side  effects  and the discussion of 
clinical case studies at weekly meetings should also be encouraged amongst the staff as it 
would also educate staff on the management of the patients as well as the side effects of 
ARVs. The wellness clinic should also access audiovisual materials (DVDs) on ARV 
products from suppliers,various nongovernmental organisations (ngo‟s)  and training service 
providers as part of the project plan. DVDs on topics such as counselling, communication, 
the monitoring of side effects, adverse reactions, quality care, staff motivation and support 
groups should be accessed  or  recorded (if it is not available) to train staff and the key role-
players as part of  the project. 
Staff at the wellness clinic should initiate support groups for HIV patients based on their 
duration of treatment on ARVs. (e.g. support group 1 is for patients under 1 year on ARVs). 
The support groups should be coordinated by the clinic manager but it could be a delegated 
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responsibility to empower  staff and patients in leading and managing a support group 
session. The support group sessions and health talks could be conducted once a month and as 
staff  or patients become more confident with the sessions, it could be expanded to one group 
session per week. It is also recommended that the Pharmacists and Pharmacist Assistants 
become more involved in these support group sessions as they are able to focus on the overall 
pharmaceutical care of the patient.  
 
It is also proposed that the following administrative interventions be introduced at the clinics. 
Standard operating procedures (SOPS)should be amended to include clear instructions on the 
counselling of patients and the reporting of the side effects of ARVs. The SOPS should 
specify the best approach that could be implemented for staff and patients. It could suggest 
that the counsellors could become part of the pharmacy human resource requirements of the 
in future. The SOP must include a reporting tool that can be used to monitor the counselling 
sessions and the reporting of the side effects. This report must be inserted in the file of the 
patient so that the healthcare provider is able to follow-up on the previous counselling 
sessions and knowledge of the patient.  
Systems at the workplace must be able to facilitate the recording and reporting of the side 
effects manually or electronically. The pharmacies should consider the use of the green card 
model as part of the workplace procedures and systems. The self reporting of the side effects 
of ARVs by patients must be encouraged by all staff and feedback must be provided to 
patients in the form of the support groups, health talks and visual aids such as graphs and 
videos. The reporting of the side effects and adverse events of ARVs must be cascaded to the 
provincial Pharmacy Therapeutic Committee (PTC) to motivate and encourage staff to report 
regularly on the side effects of ARVs.The cost of the side effects should be calculated and 
monitored to inform staff about the possible financial implications to the ART programme. 
 
The following regulatory interventions should be considered at the provincial and national 
levels. The regulatory authorities (such as MCC, NADEMC) should enforce suppliers to 
produce patient information literature and the ARV product package inserts in all official 
languages. The suppliers should produce posters and pamphlets about ARVS in adequate 
quantities (or they should outsource this function) for usage in the public healthcare 
institutions. The safety of ARV products must be communicated from the MCC to all health 
departments, provincial depots and health professionals to implement the monitoring of side 
effects and adverse reactions at various levels. 
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6.3 Implementation of the interventions 
These recommendations should be implemented as a “quality care project” at these wellness 
clinics, with the possible expansion of these practices to other public healthcare facilities in 
the province. 
 
6.4 Monitoring and evaluation of the interventions 
It is important to monitor and evaluate these interventions by compiling a standardised 
monitoring and evaluation plan with set indicators to evaluate the outcomes of this project. 
The quarterly and annual monitoring of the project is proposed for practical purposes. 
 
 
6.5 Conclusion 
 
It is important that these recommendations are not seen in isolation (as a vertical entity) but it 
needs to be incorporated as part of the daily operational practices in managing healthcare 
providers and patients at public healthcare facilities. It is hoped that these interventions could 
develop into a positive project plan that can become a best practice model in the quality care 
and management of HIV patients.  
It is further recommended that more studies (with larger sample sizes) be conducted to 
explore the perception and communication of the side effects amongst the healthcare provider 
and the patient.  
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CHAPTER 7    CONCLUSION 
 
This study concludes that staff and HIV patients (at the two public healthcare institutions in 
the Frances Baard district) are knowledgeable about the side effects of antiretroviral drugs 
(ARVs).The staff and patients at these facilities perceive the side effects of ARVS as a „bad‟ 
experience but they demonstrate a positive attitude to the side effects by reporting the side 
effects of ARVs to the respective authorities. The current practices do support the existing 
knowledge, perception and attitudes of the side effects of ARVS amongst staff and patients, 
although there is room for improving the current practises through the recommended 
interventions. It was found that patients want to know more about the side effects of ARVs 
which is in contrast to the perception of staff that patients should only be told the „common‟ 
side effects of ARVs to prevent patients defaulting or discontinuing their treatment.  
 
With the continuous training of staff and the education of the patients(by means of health 
talks, support groups, counselling and patient- friendly literature) this approach would serve a 
dual purpose in improving the communication between the healthcare provider to patient and   
it would also strengthen the approach and management of the HIV patient. 
 
In encouraging our patients to speak about their side effects, it could reduce the stigma 
associated with HIV and this would assist patients in accepting and speaking more openly 
about their condition. 
 
“In understanding the side effects of ARVs, we start to understand the management of HIV 
and that is our ultimate purpose.” 
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ADDENDA 
Addendum A: Letter of permission (Kimberley Hospital Complex) 
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Addendum B: Letter of permission (Galeshewe Day Hospital)   
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Addendum C: Patient information sheet (English) 
FORM 1 - Patient information sheet (To be read by each respondent) 
Dear Respondent/Participant 
 Exploring the knowledge, perceptions and attitudes of Antiretroviral drugs (ARVs) 
amongst patients at public healthcare institutions in the Frances Baard District of 
the Northern Cape 
In partial fulfilments of the requirements of the Master Philosophy Degree in HIV/AIDS 
Management from the Africa Centre of HIV/AIDS Management at Stellenbosch University, I 
am carrying out a study with the above title. The information you will supply is for academic 
purposes and it is anonymous and will be treated with confidentiality. The purpose of this 
study is to gather baseline information. Through the questionnaire I intend to ask the 
following research question- How much knowledge and what perceptions and attitudes do 
HIV patients have about the side effects of antiretroviral drugs (ARVs)? 
The aim of the studyis to collect data on the knowledge, attitudes and perceptions of the side 
effects of ARVs amongst HIV patients with the hope of using the information to improve 
practices at the clinic/hospital and to make recommendations in an effort to improve the 
knowledge, perceptions and attitudes about the side effects of ARVs amongst HIV patients  
The study objectives are as follows- 
1. To assess the level of knowledge of HIV patients on the side effects of ARVs  
2. To determine the perceptions of HIV patients about the side effects of ARVs 
3. To establish the attitude of HIV patients towards the side effects of ARVs 
4. To recommend interventions to promote knowledge about the side effects of ARVs 
amongst HIV patients. 
Please feel free to contact me should you have any questions or if you need clarification.  
Thank you. 
Yours sincerely  
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Addendum D:   Patient consent form (English) 
 
 
STELLENBOSCH UNIVERSITY 
CONSENT TO PARTICIPATE IN RESEARCH 
 
Exploring the knowledge, perceptions and attitudes of the side effects (unwanted effects) of 
Antiretroviral drugs (ARVs) amongst patients and staff at public healthcare institutions in the 
Frances Baard District of the Northern Cape. This consent form is applicable to patients. 
  
You are asked to participate in a research study conducted by Josephine Winley Herbert, 
B.Pharm. (U.W.C.), from the Africa Centre for HIV/AIDS at Stellenbosch University. The 
results of this research study will contribute to a research paper. You were selected as a 
possible participant in this study because you have qualified to participate in this study. 
 
1. PURPOSE OF THE STUDY  
 
o To establish the knowledge, attitude and perceptions about the side effects(unwanted 
effects) of ARVs 
o To provide recommendations to improve practices and knowledge  
 
2. PROCEDURES 
 
If you volunteer to participate in this study, we would ask you to do the following: 
 
o Read the participant information sheet(Form 1) 
o Complete this Consent form and hand the consent form back to the data 
collector(myself) once you have signed the form    
o Complete the attached questionnaire (Form 2) which the data collector hands to you. 
You need not record your name on any page of the questionnaire. Fill in all the pages 
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of this questionnaire by ticking your response and once it is completed, hand it back 
to the data collector. It should take 15-30 minutes of your time to complete. Both 
these forms will be completed while you are waiting in the queue (by the doctor or 
pharmacy).The dat collector will be seated in close proximity to you in case there are 
any queries with the completion of the forms. 
o Participants who wish to participate in the study but are illiterate will be interviewed 
by the data collector(with form 3) 
 
3. POTENTIAL RISKS AND DISCOMFORTS 
 
There are no risks to the participant that will cause the researcher to terminate the study. If 
any participant does experience any discomfort(due to the personal nature of HIV/AIDS 
questions or the personal nature of the treatment of HIV and AIDS ),the participant can feel 
free to contact the researcher who will refer him/her to the doctor/nurse/counsellor on duty at 
the clinic or hospital.  
Counselling services are available from: 
o The doctor on duty ( Galeshewe Day Hospital)  -  053 8022165 
o The doctor on duty ( Kimberley Hospital Employee Wellness Centre)  - 053   
8029111 
o The Psychologist on duty (Kimberley Hospital Complex) – 053 8029111 
o The Chief Social worker on duty ( Kimberley Hospital Complex) – 053 8029111 
 
4. POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY 
The respondent may benefit indirectly from this research as this research study intends to 
make recommendations to improve practices at the healthcare institutions so that patients and 
staff are more knowledgeable about the side effects (unwanted effects) of ARVs. It is hoped 
that the more knowledgeable the patients and staff become about the side effects(unwanted 
effects) of ARVs, the more these side effects (unwanted effects) will be reported to the 
healthcare providers and the Medicines Control Council so that we strive towards quality 
products and excellent health services.    
 
5. PAYMENT FOR PARTICIPATION 
The respondents will not receive any payment for their participation in this study. 
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6. CONFIDENTIALITY 
 
Any information that is obtained in connection with this study and that can be identified with 
you will remain confidential and will be disclosed only with your permission or as required 
by law. Confidentiality will be maintained by means of coding the questionnaires with a 
unique number. No names are recorded anywhere in the research study. The data will be 
protected on the computer (laptop) with restricted access via a password (only known to the 
data collector).No other person has access to the computer (laptop) which will be used to 
capture the data. The data will be stored on a  
removable disk and it will be backed up on a USB stick of the data collector. The completed 
questionnaires will be stored in a lockable, steel storage cabinet at the office of which there is 
only one set of keys which I carry. No information will be released to any other person except 
the statistician who will provide technical assistance to me with the analysis and compilation 
of the data for the research report. 
No activities in this study will be audio or videotaped, even for educational purposes. 
The results of this study will be compiled in a report which will be provided to the University 
of Stellenbosch and the Ministry of Health (Northern Cape) in a confidential and professional 
manner. 
 
7. PARTICIPATION AND WITHDRAWAL 
 
You can choose whether to participate in this study or not.  If you volunteer to be in this 
study, you may withdraw at any time without consequences of any kind.  You may also 
refuse to answer any questions you don‟t want to answer and still remain in the study. The 
investigator may withdraw you from this research if circumstances arise which warrant doing 
so.   
 
8. IDENTIFICATION OF INVESTIGATORS 
If you have any questions or concerns about the research, please feel free to contact Ms. 
Josephine Herbert (Researcher) or Professor J.Augustyn (Supervisor). 
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Contact details: 
Researcher : Ms. Josephine Herbert                                                        
                   Kimberley 
                   T:+27 0846806958 
                   E:jherbert55@gmail.comor  
                      jwherbert55@gmail.com   
 
Supervisor: Professor J.Augustyn 
Africa Centre for HIV/AIDS Management 
Stellenbosch University 
T: +27 083 626 3081 
E:jcda@sun.ac.za 
 
9.   RIGHTS OF RESEARCH SUBJECTS 
You may withdraw your consent at any time and discontinue participation without penalty.  
You are not waiving any legal claims, rights or remedies because of your participation in this 
research study.  If you have questions regarding your rights as a research subject, contact Ms 
Maléne Fouché [mfouche@sun.ac.za; 021 808 4622] at the Division for Research 
Development. 
 
SIGNATURE OF RESEARCH SUBJECT OR LEGAL REPRESENTATIVE 
 
The information above was described to meby Josephine Herbertin 
Afrikaans/English/Xhosa/other and I am in command of this language or it was satisfactorily 
translated to me. I was given the opportunity to ask questions and these questions were 
answered to my satisfaction.  
 
I hereby consent voluntarily to participate in this study. I have been given a copy of this form. 
 
________________________________________ 
Name of Subject/Participant 
_____________________________________ 
Name of Legal Representative (if applicable) 
 
________________________________________   ______________ 
Signature of Subject/Participant or Legal Representative  Date 
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SIGNATURE OF INVESTIGATOR  
 
I declare that I explained the information given in this document to __________________ 
and /or [his/her] representative ____________________. [He/she] was encouraged and given 
ample time to ask me any questions. This conversation was conducted in 
[Afrikaans/*English/*Xhosa/*other] and [no translator was used/this conversation was 
translated into ___________ by _______________________]. 
I declare that I explained and requested permission from the 
participant_______________________________ and /or [his/her] 
representative______________________________ to access information in his/her file 
(folder) in his/her presence for purposes of this research study only. The file (folder) will be 
accessed (only if it is necessary) to assist with the anonymous completion of the 
questionnaire. 
 
________________________________________  ______________ 
Signature of Investigator    
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Addendum E:   Patient questionnaire (English) 
 
FORM 2 -   QUESTIONAIRE FOR PATIENTS 
 
Goal: To obtain information on the knowledge, perceptions and attitudes of the side effects 
(unwanted effects) of Antiretroviral drugs (ARVs) amongst patients  
To all participants:               
This survey is conducted at this facility to provide us with information. We would like to 
learn about your knowledge, perceptions and attitudes about the side effects (unwanted 
effects) of ARVs to improve practices at this health facility. 
This in an anonymous survey and it is not required for you to write your name on this 
questionnaire. Your participation is voluntary and it should take 15-30 minutes to complete 
this questionnaire.  
Please answer all the questions on all the pages. PLEASE TICK YOUR RESPONSE.   
 
 
 
 
GENERAL QUESTIONS 
1. How old are you? 
□   15-19        □ 20-29       □  30- 39       □  40-49       □ 50-59       □  60-69      □ 70-79    □ 
Above 80 yrs 
2. What is your gender? 
□   Male                                                         □    Female 
 
3. What is the highest level of education you have completed? 
□   Std 5 (grd 7)        □ Std 10 (grd 12)       □ College         □ University       □ other (please 
explain)......... 
 
KNOWLEDGE QUESTIONS 
 
4. Is there a cure for HIV? 
□ Yes                                                                                                     □ No 
Institution: ………………………………………… Questionnaire no: .............. 
Date: ……………….................               
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5. What treatment is provided at a clinic/hospital to a person with HIV?  
□ARVs and other medicines       □ Herbal medicines         □ Traditional medicines     
 □Don‟t know                           □Other (please explain) ………………………….................… 
6. Are you taking ARVs? 
□   Yes                                                                                                    □   No 
7. How long have you been taking ARVs? 
□   0 yrs         □ 1 year       □ 2 years     □ 3 years      □ 4 years    □ 5 years       □ 6 years    
□ other.........................................................................................................................................  
 
8. Do you know the names of your ARVs? 
□   All of them                  □   Most of them                 □    some of them               .     □   none 
of them  
 
9. How do you take your ARVs? Please explain. 
………………………………………………………………………………………………….. 
…………………………………………………………………………………………………. 
 
10. Are you taking other medicines or herbs or traditional mixtures with your ARVs? 
□   Yes (Please explain)...................................                              □   No 
 
11. Do you think it is important to take your ARVs as you are told at the clinic? 
□   Yes (Please explain).................................  □   No (Please explain)....................................... 
 
12. When you take your ARVs do you follow the instructions exactly as you are told at the 
clinic? 
□   All of the time             □    Most of the time              □    Sometimes       □   Never   
 
13. Do you know what will happen if you stop taking your ARVs? (More than 1 answer can 
be ticked) 
□   You could die        □   You could become resistant to ARVS        □ You could develop 
AIDS          □ Nothing will happen                      □ I don‟t know 
 
14. Have you been told about the side effects (unwanted effects)   of ARVs? 
□ Yes                                                                                                      □ No 
 
15.   What is a side effect (unwanted effect) of an ARV? (Please explain) 
......................................................................................................................................................
............................................................................................................................................. 
16. Who told you about the side effects (unwanted effects) of ARVs? (More than one answer 
can be ticked here) 
□ Doctor     □ Nurse     □   Pharmacist   □ Pharmacist Assistant    □ Counsellor     
□ Other...................................................................................................................................... 
 
17. When do they tell you about the side effects (unwanted effects) of ARVs? (More than one 
answer can be ticked here) 
□   When you start ARVs       □ Every month      □ Every 3 months        □ Never        □ I don‟t 
know   
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PERCEPTION 
 
18.  Do you think the side effects (unwanted effects) of ARVS are something good or 
something bad? 
□ Very good       □ Good             □ Not good or bad             □ Bad          □ Very bad        
□ I don‟t know 
 
19. Do you think that the side effects (unwanted effects) of ARVs are serious or something 
not to worry about? 
□ Very serious       □ Serious          □ A little serious     □   Not serious        □ Nothing to 
worry about 
 
20. What do you think causes the side effects (unwanted effects) of ARVs? 
......................................................................................................................................................
...................................................................................................................................................... 
21. Do you think that the side effects (unwanted effects) of ARVs can be stopped or 
discontinued? 
□   Yes                                                                                                    □   No 
 
22. How many side effects (unwanted effects) do you think can be stopped? 
□   All of them        □   Most of them          □ Some of them        □ None of them         
□ I don‟t know 
 
23. Do you think that side effects can change the longer you are on treatment with ARVs? 
□   Yes                                              □   No                                    □ I don‟t know 
 
24. Is it difficult for you to understand the side effects of ARVs? 
□   Yes                                                                 □   No 
 
25. If yes (in no.24 above) please explain your answer. 
......................................................................................................................................................
.................................................................................................................................................. 
26. Do you look for the side effects (unwanted effects) or any changes in your body if you 
take your ARVs? 
□   Yes                                                               □   No  
 
27. Are you told about the side (unwanted effects) of ARVs at every clinic visit? 
□ All the time         □   Most of the time          □   Sometimes             □   Never             
□   Don‟t know 
 
28. Do they tell you about the sameor different side effects every time you visit the clinic? 
□ Yes (explain)...............................          □ No (explain).......................................................... 
 
29. Do you think the staff at the clinic know about the side effects (unwanted effects) of 
ARVs? 
□   All of them        □   Most of them         □ Some of them      □   None of them       
□   I don‟t know 
 
30. Do you think that other HIV patients know about the side effects (unwanted effects) of 
ARVs? 
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□   All of them       □   Most of them     □   Some of them      □   None of them        
□ I don‟t know 
 
ATTITUDE 
31. What do you do when you experience any side effect (unwanted effect) of your ARVs? 
□   Stop taking the specific   ARV that you think is causing the problem       □   Stop taking 
all the ARVS         □    Don‟t do anything             □   Other........................................... 
 
32. Do you report the side effects (unwanted effects) of the ARVs? 
□   All the time     □ Most of the time     □   Sometimes         □   No, I don‟t report it        □ I 
don‟t know how to report it 
 
33. To whom do you report the side effects (unwanted effects) of the ARVs? 
□   Doctor       □   Nurse        □   Pharmacist        □    Pharmacist Assistant      □   A friend       
□    A family          Member              □ Nobody                  □ Other...................................... 
 
34. Do you want to know more about the side effects (unwanted effects) of ARVs? 
□   Yes                                                                                                   □   No             
 
35. Do you ask questions about the side effects (unwanted effects) of ARVs at your clinic? 
□   All the time      □   Most of the time      □   Sometimes        □   Never         □ I don‟t know 
how to ask 
 
36. Do you read more about the side effects (unwanted effects) of ARVs? 
□ All the time □ Most of the time   □ Sometimes   □ Never    □ I don‟t know where to get 
information 
 
37. What do you think will assist HIV patients to know more about the side effects (unwanted 
effects) of ARVs? 
□   Posters             □   Pamphlets                □   Counselling             □   Support groups‟        □    
Health talks‟            □   Patient diaries       □ I don‟t know        □ Other............................... 
 
38. How many side effects (unwanted effects) of each ARV do you think they must tell you 
about when you visit the clinic? 
□   0 (none)                 □   1                       □   2                      □   3                     □    4           
□ I don‟t know 
 
39. When must they tell you about the side effects (unwanted effects) of your ARVs? 
□   Every month      □   Every 2 months      □    Every 3 months      □   Every 6 months           
□   Never 
 
40. Do you have any suggestions how the clinic can improve its services so that all HIV 
patients know and understand the side effects (unwanted effects) of ARVs? 
........................................................................................................................................... 
........................................................................................................................................... 
 
THANK YOU FOR YOUR PARTICIPATION 
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Addendum F:  Patient interview schedule for illiterate patients (English)  
 
Form 3-Interview schedule for respondents/participants (e.g. illiterate patients) 
 
Opening 
 
After observing the response and reaction of the respondent in answering the self 
administered questionnaire, I shall interview the respondent. During the interview I would 
like to ask some questions about the participant‟s age, gender, educational background, the 
knowledge of antiretroviral drugs (ARVs) as well as the perception, the attitudes and 
knowledge about the side effects of ARVs. 
The interview should take 30 to 45 minutes.  
The interview will be semi-structured, guided by the following kinds of questions: 
A.  General demographic information 
1.        Age 
2.        Gender 
3.        Educational background 
 
B.  Background information about ARVs 
1. How long have you been on the antiretroviral drugs (ARVs)? 
2.  Do you know about the names of your ARVs? 
3.  What side effects of ARVs have/do you experience? Please explain your    
            answer 
4.  Do you report any side effects of ARVs to a healthcare worker? Please  
            explain your answer 
5. If yes - when, where and how is this reported?  
C. Knowledge strategy 
1. What is a side effect of ARVs? 
2.      During your visits to this clinic do you receive information about the side effects 
of ARVs? 
3. If yes, when, who and how is this provided? 
4. Are their other ways that information on the side effects of ARVs can be 
provided to HIV patients? 
D. Perception 
            1.        Are side effects of ARVs good or bad? 
            2.        Do you think the side effects of ARVs can change over time? 
E. Attitude 
           1.         Is it easy to understand the side effects of ARVs? 
Please explain your answer. 
   2.        What will make it easier for you to understand the side effects of ARVs? 
F.        Closing 
           1.        Are there any other matters regarding the knowledge, perceptions or attitudes?      
                    of the side effects of ARVs that you would like to emphasise? 
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Addendum G: Staff information sheet (English) 
FORM 1 - Staff information sheet (To be read by each respondent) 
Dear Respondent/Participant 
Re:  Exploring the knowledge, perceptions and attitudes of Antiretroviral drugs 
(ARVs) amongst staff at public healthcare institutions in the Frances Baard District 
of the Northern Cape 
In partial fulfilments of the requirements of the Master Philosophy Degree in HIV/AIDS 
Management from the Africa Centre of HIV/AIDS Management at Stellenbosch University, I 
am carrying out a study with the above title. The information you will supply is for academic 
purposes and it is anonymous and will be treated with confidentiality. The purpose of this 
study is to gather baseline information. Through the questionnaire I intend to ask the 
following research question- How much knowledge and what perceptions and attitudes do 
staff have about the side effects of antiretroviral drugs (ARVs)? 
The aim of the studyis to collect data on the knowledge, attitudes and perceptions of the side 
effects of ARVs amongst staff with the hope of using the information to improve practices at 
the clinic/hospital and to make recommendations in an effort to improve the knowledge, 
perceptions and attitudes about the side effects of ARVs amongst staff members.  
The study objectives are as follows- 
1. To assess the level of knowledge on the side effects of ARVs amongst staff. 
2. To determine the perceptions of the side effects of ARVs amongst staff. 
3. To establish the attitude of staff towards the side effects of ARVs 
4. To recommend interventions to promote knowledge about the side effects of ARVs 
amongst staff members. 
Please feel free to contact me should you have any questions or if you need clarification. 
Thank you. 
Yours sincerely  
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Addendum H: Staff consent form (English) 
 
 
 
 
STELLENBOSCH UNIVERSITY 
CONSENT TO PARTICIPATE IN RESEARCH 
 
Exploring the knowledge, perceptions and attitudes of the side effects of antiretroviral drugs 
(ARVs) amongst staff at public healthcare institutions in the Frances Baard District of the 
Northern Cape. This consent form is applicable to staff members. 
 
You are asked to participate in a research study conducted by Josephine Winley Herbert, 
B.Pharm. (U.W.C.), from the Africa Centre for HIV/AIDS at Stellenbosch University. The 
results of this research study will contribute to a research paper. You were selected as a 
possible participant in this study because you have met the criteria to participate in this study. 
 
1. PURPOSE OF THE STUDY 
 
The study is designed to collect baseline information on the knowledge, perceptions and 
attitudes of the side effects of antiretroviral drugs (ARVs) amongst staff at the Galeshewe 
Day Hospital and the Kimberly Hospital Complex and to make recommendations in an effort 
to improve the perceptions, attitudes and knowledge about the side effects of ARVs amongst 
staff and patients.  
 
2. PROCEDURES 
 
If you volunteer to participate in this study, we would ask you to do the following things: 
a. Read the participant information sheet (Form 1)  
b. Complete this Consent form 
c. Complete the attached questionnaire for staff (Form 2, pgs 1 - 4) 
d. Forms 1, 2 and this consent form will be available in English.  
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Handout of forms 
The participant will be provided forms 1, 2 and this consent form by the data collector for 
him/her to read in a private place at the clinic/hospital. It should take 10-20 minutes for 
him/her to read through all the forms. 
Completion of forms 
He/she will complete this consent form, as well as form 2 in a black pen. The consent form 
must be read and signed by the participant. It should take 5- 20 minutes to complete this 
consent form.With form 2, all questions must be answered and all pages must be completed 
.It should take 20 – 30 min to complete form 2.The completed forms will be handed back to 
the data collector. 
All the completed forms will then be collected and securely stored with the data collector. 
 
3. POTENTIAL RISKS AND DISCOMFORTS 
 
There are no foreseen physical or psychological risks to participation that might cause the 
researcher to terminate the study. 
This research study is considered to be classified as a medium risk category as the research 
questions enquire about his/her knowledge about his/her antiretroviral drugs (ARVs) as well 
as personal information about the perception, attitude and knowledge about the side effects of 
antiretroviral drugs (ARVs). 
 
Any discomfort experienced by the participant with the reading and completion of the 
consent form and forms 1 and 2 will be handled with confidentiality and professionalism. The 
participant will be referred to the doctor at the clinic or hospital to reduce the impact of the 
risk of discomfort. 
 
4. POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY 
 
The respondent will not benefit from this research. This research study intends to make 
recommendations to improve practices at the healthcare institutions so that staff are more 
knowledgeable about the side effects of ARVs. It is hoped that the more knowledgeable the 
staff are about the side effects of ARVs, the more these side effects will be communicated to 
patients and healthcare providers and with time, more side effects of ARVs will be reported 
Stellenbosch University  http://scholar.sun.ac.za
 116 
 
by staff to the Medicines Control  Council so that quality ARVS are produced for HIV 
patients.  
 
5. PAYMENT FOR PARTICIPATION 
 
The respondents will not receive any payment for participation in this study. 
 
6. CONFIDENTIALITY 
 
Any information that is obtained in connection with this study and that can be identified with 
you will remain confidential and will be disclosed only with your permission or as required 
by law. Confidentiality will be maintained by means of coding the questionnaire (form 2) 
with a unique number. All completed questionnaires will be safely stored in a secure storage 
place having a restricted access to these documents. Data from the completed questionnaires 
will be captured on a laptop of the data collector and it will be stored on a removable disk ad 
backed up on a USB stick of the data collector and statistician. Access to the laptop of the 
data collector is restricted and accessible with the use of a pin code (only known to the data 
collector) 
Data that is collected will be released to the statistician only for purposes of analyzing the 
results of the study and presenting the results in professional, technical and analytical manner 
for academic purposes. 
No activities in this study will be audio or videotaped, even for educational purposes. 
 
The results of this study will be formulated as a report which will be provided to the 
University of Stellenbosch and the Ministry of Health (Northern Cape) in a confidential and 
professional manner.  
 
7. PARTICIPATION AND WITHDRAWAL 
 
You can choose whether to be in this study or not.  If you volunteer to be in this study, you 
may withdraw at any time without consequences of any kind.  You may also refuse to answer 
any questions you don‟t want to answer and still remain in the study. The investigator may 
withdraw you from this research if circumstances arise which warrant doing so.   
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8. IDENTIFICATION OF INVESTIGATORS 
 
If you have any questions or concerns about the research, please feel free to contact Ms. 
Josephine Herbert or Professor J.Augustyn. 
Contact details: 
 
Researcher : Ms. Josephine Herbert                                                        
                   Kimberley 
                   T:+27 0846806958 
                   E:jherbert555@gmail.com or 
                      jherbert@msh.org 
Supervisor: Professor J.Augustyn 
Africa Centre for HIV/AIDS Management 
Stellenbosch University 
T: +27 083 626 3081 
E:jcda@sun.ac.za 
 
9. RIGHTS OF RESEARCH SUBJECTS 
You may withdraw your consent at any time and discontinue participation without any 
penalty.  You are not waiving any legal claims, rights or remedies because of your 
participation in this research study.  If you have questions regarding your rights as a research 
subject, contact Ms Maléne Fouché [mfouche@sun.ac.za; 021 808 4622] at the Division for 
Research Development. 
 
SIGNATURE OF RESEARCH SUBJECT OR LEGAL REPRESENTATIVE 
The information above was described to [me/the subject/the participant] by Josephine 
Herbertin [Afrikaans/English] and [I am/the subject is/the participant is] in command of this 
language or it was satisfactorily translated to [me/him/her].[I/the participant/the subject] was 
given the opportunity to ask questions and these questions were answered to [my/his/her] 
satisfaction.  
[I hereby consent voluntarily to participate in this study/I hereby consent that the 
subject/participant may participate in this study.] I have been given a copy of this form. 
________________________________________ 
Name of Subject/Participant 
________________________________________ 
Name of Legal Representative (if applicable) 
________________________________________   ______________ 
Signature of Subject/Participant or Legal Representative Date 
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SIGNATURE OF INVESTIGATOR  
 
I declare that I explained the information given in this document to __________________ 
and /or [his/her] representative ____________________. [He/she] was encouraged and given 
ample time to ask me any questions. This conversation was conducted in 
[Afrikaans/*English/*Xhosa/*other] and [no translator was used/this conversation was 
translated into ___________ by _______________________]. 
 
________________________________________                         ______________ 
Signature of Investigator     Date 
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Addendum I: Staff questionnaire (English) 
 
FORM 2 -   QUESTIONAIRE FOR STAFF MEMBERS 
 
Goal: To collect data on the knowledge, perception and attitudes of the side effects of 
antiretroviral drugs (ARVS) amongst staff.  
To all participants:   
This survey is conducted at this facility to provide us with information. We would like to 
learn about your knowledge, perception and attitudes of ARVS to improve practices at this 
health facility. This in an anonymous survey and it is not required for your name to be 
recorded on this questionnaire. Your participation is voluntary and it should take 15-30 
minutes of your time.  
Please answer all questions on all 4 pages. Please circle your selected response.   
 
 
 
 
 
GENERAL QUESTIONS 
 
1. How old are you? 
a. 15-19           b. 20-29              c.  30- 39                d.  40-49                e. 50-59          f.  60-69      
 
2. What is your gender? 
a. Male                                                                 b.  Female 
 
3. What is the highest level of education you have completed? 
a.Std 5 (grd 7)   b. Std 10 (grd 12) c. College   d. University   e.Other (please 
explain)........................... 
 
KNOWLEDGE QUESTIONS 
 
4. Can HIV be cured? 
a. Yes                                                                   b. No 
 
5. What treatment is provided at this clinic/hospital to a person with HIV?  
a.ARVs and medicines   b. Herbal medicines   c. Traditional medicines   d. Don‟t know   
e.Other (please explain) …………………………………................................................... 
 
6.  Do you know the names of ARVS? 
a. Yes (explain)............................................................................................................................ 
b.No (explain)............................................................................................................................. 
 
Institution: ………………………………           Questionnaire no: …………… 
Date: ……………….................               
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7. Do you know the dosaging and frequency of ARVS? 
a. Yes (explain).................................................................................................................... 
b.No (explain)...................................................................................................................... 
 
8. What is a side effect of an ARV? (explain) 
......................................................................................................................................................
......................................................................................................................................................
.............................................................................................................................................. 
9. Have you been told about the side effects of ARVS? 
a. Yes                                                                      b. No 
 
10. Who informed you about the side effects of ARVS? (More than 1 can be circled here) 
a. Doctor   b. Nurse     c. Pharmacist    d. Pharmacist Assistant    e. Counsellor 
f.Other..................................... 
 
11. Do you think that the side effect of ARVS is something serious? 
a. Very serious     b. Serious           c. A little serious    d. Not serious         e.  Nothing to 
worry about 
 
12 What do you think causes side effects of ARVS? 
......................................................................................................................................................
......................................................................................................................................................
............................................................................................................................................. 
13. Do you think that the side effects of ARVS can be stopped or discontinued? 
a. Yes                                                                 b. No 
 
14. How many side effects do you think can be stopped? 
a. All of them      b. Most of them     c. Some of them     d. None of them     e. I don‟t know 
 
15. Do you think that side effects can change over time with the treatment of ARVS? 
a. Yes                                                                b.No 
 
16 Did you receive training about the side effects of ARVS? 
a. Yes                                                                b.No 
 
17. When and where did you receive training about the side effects of ARVs? Please explain. 
......................................................................................................................................................
..............................................................................................................................................  
 
PERCEPTION 
 
18.  Do you think the side effects of ARVS are good or bad? 
a. Very good       b. Good             c. Neutral             d. Bad           e. Very bad             f. Don‟t 
know 
 
19. Is it difficult to understand the side effects of ARVS? 
a. Yes                                                                b.No 
 
20. If yes (in no.19 above) please explain............................................................................. 
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21. Do you think patients know about the side effects of ARVS? 
 
a. All of them      b. Most of them     c. Some of them     d. None of them     e. I don‟t know 
 
22. Do you think patients must know about the side effects of ARVS? 
a. Yes (explain)..................................................b.No (explain).............................................. 
 
23. Do you think patients look for the side effects of ARVS or any changes in their body? 
a. Yes                                       b.No                                   c. I don‟t know     
 
24. Do you think that patient knowledge about side effects of ARVS is linked to adherence? 
a. Yes                                      b.No                                 c. I don‟t know 
 
25. When do you think must patients be told about the side effects of ARVS? 
a. Never    b. Before starting treatment  c. Upon initiation of treatment.    d. After 1 month on 
treatment       e. After 3 months on treatment            f. After 6 months on treatment       g. 
After 1 year on treatment     h. With every visit 
i. Other (explain)........................................................................................................................ 
 
26. Do you think staff members at this facility know about the side effects of ARVS? 
a. All of them        b. Most of them   c. Some of them     d. None of them    e.I don‟t know 
 
27. Whom do you think must inform patients about the side effects of ARVS? 
e.Counsellor    b. Doctor    c.Pharmacist  d.Pharmacist Assistant                                e. Nurse 
f.Other (explain)................................................................................... 
 
28. Do you think there is enough time spent educating patients about the side effects of 
ARVS? 
a. Yes                                       b.No                                c. I don‟t know 
 
ATTITUDE   
 
29. Do you inform patients about the side effects of ARVS? 
a. All the time    b.Most of the time    c. Sometimes      d. Never       
e. I don‟t know how to do it 
 
30. Do you tell them the same side effects each time they visit the clinic/hospital? 
a. Yes (explain)..........................................  b. No (explain)....................................................... 
 
31. How many side effects do you tell them of each ARV? 
a.0                      b.1                c.2                       d.3                 e.4              f.Other................. 
 
32. How do you decide how many side effects you must tell the patient?  Please  
explain..........................................................................................................................................
......................................................................................................................................................
............................................................................................................................................... 
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33. Do you tell them the general side effects or specific side effects of ARVS?                                       
a. General side affects                                        b.Specific side effects 
34. When patients tell you their side effects of ARVS what do you do? 
a. Stop the ARVS   b. Refer the patient to a doctor    c.Dont do anything    
d. Report it e. Other............................................................................... 
 
35. Do you report the side effects of the ARVS? 
a. All the time   b.  Most of the time  c.Sometimes    d.  No, I don‟t report it   
e. I don‟t know how 
 
36. To whom do you report the side effects of ARVS? 
a. Doctor      b. Nurse    c. Pharmacist   d. Pharmacist Assistant    
e. Medicines safety centre   f. Nobody   g. Other....................................... 
 
37. Do you want to know more about the side effects of ARVS? 
a. Yes                                                               b. No             
 
38. Do you ask questions about the side effects of ARVS? 
a. All the time    b. Most of the time c. Sometimes      d. Never   
e.I don‟t know who to ask 
 
39. Do you read more about the side effects of ARVS? 
a. All the time    b. Most of the time c. Sometimes      d. Never  
e.    I don‟t know where to get info 
 
40. What will assist HIV patients to know more about the side effects of ARVS? 
 
a. Posters    b. Pamphlets    c. Counselling     d. Support groups   e. Health talks 
 f. Patient diaries          g. Don‟t know                        h.Other.................................................... 
 
41. Do you have any suggestions how the clinic/hospital can improve its services so that staff 
know and understand the side effects of ARVS? 
..................................................................................................................................................... 
..................................................................................................................................................... 
 
 
 
THANK YOU FOR YOUR PARTICIPATION 
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